Menu
Close
| 21 December 2015 | Administrative Order No. 2015-0053 | Implementing Guidelines on the Promotion and Marketing of Prescription Pharmaceutical Products and Medical Devices |
| 03 March 2004 | DOH Department Circular No. 96s 2004 | Revised Implementing Rules and Regulations ofRepublic Act No. 8172 "An Act Promoting Salt Iodization Nationwide and for Related Purposes" |
| Administrative Order No 238 s. 1975 | Regulation B-4. 13 Jams (Fruit Preserves) and Jellies b-4. 13-01 Jams (Naming the Fruit) |
|
| 28 December 2006 | Bureau Circular No. 2006 - 018 | Additional Requirements in the Registration of Virgin Coconut Oil Food Supplement with Flavor |
| 18 November 1985 | Administrative Order 136-a s. 1985 | Standard for Instant Coffee |
| 18 November 1985 | Administrative Order No. 136-B s. 1985 | Standard for Soluble Coffee with Carbohydrates |
| Administrative Order No. 235 s. 1975 | "Regulation B- 4 Definitions and Standards for Food B- 4.6 Dressing for Food B- 4.6.-01 Mayonaise (Mayonnaise Dressing and Mayonnaise Salad Dressing)" |
|
| 19 May 1988 | Memorandum Circular No. 88-003 | Methanol Content in Alcoholic Beverages |
| 28 March 2023 | Administrative Order 136-A s. 1985 | Standard for Instant Coffee |
| 28 March 2023 | Administrative Order 136-B s. 1985 | Standard for soluble coffee with added carbohydrates. |
| 28 March 2023 | Administrative Order 238 s. 1975 | Regulation B-4 Definitions and Standards for Food B-4.13 Jams (Fruit Preserves) and Jellies B-4.13-01 Jams (Naming the Fruit) |
| 28 March 2023 | Administrative Order 235 s. 1975 | Regulation B-4. Regulations and Standard for Food. B-4.6 Dressing for Food B-4.6-01 Mayonnaise (Mayonnaise Dressing and Mayonnaise Salad Dressings) |
| 28 March 2023 | Bureau Circular 2006-018 | Additional Requirements in the Registration of Virgin Coconut Oil Food Supplement with Flavor |
| 06 June 2018 | FDA Memorandum No. 2018-011 | REGULATION OF TOOTHBRUSH, SANITARY NAPKINS AND BABY DIAPERS |
| 10 January 2000 | Administrative Order No. 3-A s. 2000 | Guidelines on Vitamin A and Iron Supplementation |
| 7 January 2000 | Administrative Order No. 3-B s. 2000 | Guidelines for Assistance/Sponsorship by Manufacturers of Products Covered by Executive Order 51 (Milk Code) |
| 11 December 2000 | Administrative Order No. 163-B s. 2000 | Revised Schedule of Fees and Charges for the services rendered by the Bureau of Food and Drugs |
| 24 January 2001 | Administrative Order No. 177 s. 2001 | Amendment to Administrative Order No.117 s. 2000 Relative to the Guidelines on the Accreditation of Suppliers of Medical Equipment, Parts, Accessories and Medical Equipment Repair Shop |
| 02 December 2003 | Administrative Order No. 119 s. 2003 | Updated Guidelines on Micronutrient Supplementation (Vitamin A, Iron, and Iodine) |
| 03 September 2003 | Administrative Order No. 82 s. 2003 | Guidelines on the Granting of Diamond Sangkap Pinoy Seal to Manufacturers of Fortified Products |
| 06 June 2003 | Administrative Order No. 54-A s. 2003 | Guidelines on the Processing and Clearance of Importations through Donations by the Department of Health |
| 12 November 2004 | Administrative Order No. 177 s. 2004 | Amendment to Administrative Order No.171 s. 2004 on the Policies and Guidelines to Implement the Relevant Provisions of Republic Act 9257, Otherwise Known as the Expanded Senior Citizens Act of 2003 |
| 01 October 2004 | Administrative Order No. 171 s. 2004 | Policies and Guidelines to Implement the Relevant Provisions of Republic Act 9257, Otherwise Known as the "Expanded Senior Citizens Act of 2003" |
| 06 September 2004 | Administrative Order No. 169 s. 2004 | Implementing Guidelines for the Exclusive Use of Generic Names or Generic Terminology in all Prescriptions and Orders in all DOH Facilities |
| 07 May 2004 | Administrative Order No. 153 s. 2004 | Revised Guidelines on Current Good Manufacturing Practice in Manufacturing, Packing, Repacking or Holding Food |
| 09 January 2004 | Administrative Order No. 134 s. 2004 | Guidelines Governing the Registration and Performance Evaluation of Drug Screening Test Kits and Reagents |
| 03 January 2005 | Administrative Order No. 2005-0001 | Revised Policies and Guidelines Governing Patent and Trade Secret Rights in relation to the Registration of Pharmaceutical Products |
| 07 March 2006 | Administrative Order No. 2005-0003-B | Amendment to AO 2005-0003 dated January 11, 2005 re: Guidelines on the Issuance of Certificate of Product Registration for Water Purification Equipment and Device |
| 08 June 2009 | Administrative Order No. 2005-0003-C | Addendum to Administrative Order No. 2005-0003 " Guidelines on the Issuance of Certificate of Product Registration for Water Purification Equipment and Device" |
| 31 March 2005 | Administrative Order No. 2005-0007 | Amending Administrative Order No.142, s.2004 by Providing Exemption from the Requirement of Certificate of Product Registration for All Goods Procured Through UNICEF, UNDP WHO, and GDF |
| Administrative Order No. 2005-0008 | Policy and Requirements for Availing of Special Permit for Restricted Use of Unregistered Drug and Test Kits for Human Immune Deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) | |
| 04 April 2005 | Administrative Order No. 2005-0011 | Supplemental -Guidelines to Administrative Order No. 144 Series 2004, Entitled ".Guidelines for the Establishment and Operations of Botika ng ''Barangays (BnB) and Pharmaceutical Distribution (PDNs)" Relative to the Inclusion of Other Drugs which are Classified as Prescription Drugs and other Related Matters |
| 06 October 2005 | Administrative Order No. 2005-0025 | Implementation of the ASEAN Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents |
| 07 December 2005 | Administrative Order No. 2005-0030 | Guidelines and Procedure For the Automatic Renewal of the Certificate of Product Registration issued by the Bureau of Food and Drugs |
| 07 December 2005 | Administrative Order No. 2005-0031 | Guidelines and Procedure For the Issuance of the Principal Certificate of Product Registration and the Listing of Identical Drug Products based on the Identity of Manufacturer and Pharmaceutical Formulation |
| 08 January 2007 | Administrative Order No. 2007-0003 | Policies and Guidelines Governing the Registration and Licensing of Establishments Dealing with Medical Devices |
| 14 March 2007 | Administrative Order No. 2007-0014 | Guidelines on the Issuance of Certificate of Product Registration for Equipment or Devices Used for Trating Sharps, Pathological and Infectious Waste |
| 30 July 2008 | Administrative Order No. 2008-0021 | Gradual Phase-out of Mercury in All Philippine Health Care Facilities and Institutions |
| 22 October 2008 | Administrative Order No. 2008-0030 | Renaming the National Codex Committee (NCC) to the National Codex Organization (NC0) and Amending Its Terms of Reference (TOR) |
| 18 March 2010 | Administrative Order No. 2010-0008 | Directive Specific to the Change in the Use of Phrase "No Approved Therapeutic Claim" in all Advertisement, Promotional, and/or Sponsorship Activities or Materials Concerning Food/Dietary Supplements |
| 11 October 2013 | Administrative Order No. 2013-0031 | Requirements for the Operation of a Therapeutic X-ray Facility Utilizing Medical Linear Accelerators |
| 11 April 2014 | Administrative Order No. 2014-0016 | Adoption of the World Health Organization "Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs)" for the Registration of Biosimilar Products" |
| 13 October 2014 | Administrative Order No. 2014-0034 | Administrative Order No.2014-0034 || Rules and Regulations on the Licensing of Establishments Engaged in the Manufacture, Conduct of Clinical Trial, Distribution, Importation, Exportation, and Retailing of Drug Products, and Issuance of Other Related Authorizations |
| 27 October 2014 | Administrative Order No. 2014-0038 | Rules and Regulation Governing Household / Urban Pesticides Licensing of Establishment and Operators, Registration of Their Products and for Other Purpose |
| 27 October 2014 | Administrative Order No. 2014-0040 | REVISED GUIDELINE ON THE NEED / ROLE OF A MEDICAL DIRECTOR IN THE PHARMACEUTICAL INDUSTRY |
| Administrative Order No. 2014-0042 | Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines | |
| 08 September 2015 | Administrative Order No. 2015-0038 | REMOVING THE REQUIREMENTS OF LICENSING AS IMPORTERS, EXPORTERS, MANUFACTURERS, TOLL MANUFACTURERS, WHOLESALERS, DISTRIBUTORS, RETAILERS, OR RE-PACKERS OF THOSE ENGAGE IN CERTAIN HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES, AND FROM THE REQUIREMENT OF PRIOR REGISTRATION AND/OR NOTIFICATION OF SAID PRODUCTS |
| 15 February 2016 | Administrative Order No. 2016-0003 | Guidelines on the Unified Licensing Requirements and Procedure of the Food and Drug Administration (FDA) |
| 02 March 2016 | Administrative Order No. 2016-0008 | Revised Rules and Regulations Governing the Generic Labeling Requirements of Drug Products for Human Use |
| 23 June 2017 | Administrative Order No. 2017-0010 | Philippine National Standards for Drinking Water of 2017 |
| 14 June 2019 | Administrative Order No. 2019-0007 | Revised Rules and Regulations on Electronic Nicotine and Non-Nicotine Delivery System (ENDS/ENNDS) |
| 04 June 2018 | Administrative Order No. 2018-0016 | Revised Guidelines in the Implementation of the One-Stop Shop Licensing System |
| 08 May 2020 | Administrative Order No. 2020-0017 | Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003 |
| 06 March 2020 | Administrative Order No. 2020-0010 | Regulations on the Conduct of Clinical Trials for Investigational Products |
| 08 July 2010 | FDA Memorandum Circular No.2010-012 | Republic Act No. 9442 and Its Implementing Rules and Regulations |
| 18 October 2010 | FDA Memorandum Circular No.2010-019 | Suspension of Manufacture, Importation, Distribution, and/or Marketing of Sibutramine Products |
| 18 October 2010 | FDA Memorandum Circular No.2010-020 | Suspension of Manufacture, Importation, Distribution, and/or Marketing of All Rosiglitazone-Containing Products |
| 27 June 2012 | FDA Memorandum Circular No.2012-004 | Adoption of PIC/S GMP Guide |
| 03 April 2012 | FDA Memorandum Circular No.2012-003 | Full Compliance to Good Manufacturing Practice (GMP) |
| 30 March 2012 | FDA Memorandum Circular No.2012-002 | Submission of Certificate of Analysis of Imported and Locally-Manufactured Lipsticks |
| 06 January 2014 | FDA Memorandum Circular No. 2014-001 | Extension of Deadline to Submit Electronic Copy of All Registered Drug Products' Dossier |
| 14 January 2014 | FDA Memorandum Circular No. 2014-002 | New License to Operate Format for Drug Establishments |
| 28 January 2014 | FDA Memorandum Circular No. 2014-003 | Issuance of License to Operate (LTO) with New Format for All Cosmetic and HUHS Establishments Using the FDA Security Paper |
| 10 February 2014 | FDA Memorandum Circular No. 2014-004 | Release of Promo and Advertisement Permits |
| 25 February 2014 | FDA Memorandum Circular No. 2014-005 | Updated List of Medical Devices Required to be Registered Prior to Sale, Distribution and Use |
| 03 June 2015 | FDA Memorandum Circular No. 2014-005-A | Amendment to FDA Memorandum Circular No. 2015-005, "Updated List of Medical Devices Required to be Registered Prior to Sale, Distribution and Use" |
| 25 March 2014 | FDA Memorandum Circular No. 2014-006 | Optional Courier Service |
| 16 April 2014 | FDA Memorandum Circular No. 2014-007 | Issuance of Official Receipt (OR) for Bank Payments and Full Implementation of Online Collection (OnColl) Facility of LandBank of the Philippines for Electronic Cosmetic Notification |
| 29 April 2014 | FDA Memorandum Circular No. 2014-008 | Guidelines on the Electronic Notification of Selected Household Urban Hazardous Substance (HUHS E-Notification) System |
| 09 May 2014 | FDA Memorandum Circular No. 2014-008-A | Amendment to FDA Memorandum Circular 2014-008 "Guidelines on the Electronic Notification of Selected Household/Urban Hazardous Substances (HUHS E-Notification) System |
| 04 August 2014 | FDA Memorandum Circular No. 2014-009 | Issuance of License to Operate (LTO) with a new format for all Toys and Child care articles establishments using the FDA Security Paper |
| 03 September 2014 | FDA Memorandum Circular No. 2014-012 | Payent of FDA Academy and Seminar Fees in all branches of the Development Bank of the Philippines |
| 01 February 2016 | FDA Memorandum Circular No. 2014-012-A | Amendment to FDA Memorandum Circular No. 2014, " Payment of FDA Academy Training and Seminar Fees in all Branches of Development Bank of the Philippines |
| 06 November 2014 | FDA Memorandum Circular No. 2014-014-A | Guideline on Placement of Advertisement in All forms of Mass Social Media, Billboards and Public Transport |
| 20 November 2014 | FDA Memorandum Circular No. 2014-015 | Display of Antimicrobial Resistance (AMR) Infomercial |
| 01 December 2014 | FDA Memorandum Circular No. 2014-016 | Administration of Customer Satisfaction Survey |
| 11 December 2014 | FDA Memorandum Circular No. 2014-017 | Correction on Annex III / PArt I Ref. No. 1a; Boric Acid, Borates and Tetraborates with the Exception of Substance No. 1184 in Annex II |
| 27 November 2013 | FDA Memorandum Circular No.2013-046 | Payment Collection of FDA fees and charges |
| 14 November 2013 | FDA Memorandum Circular No.2013-045 | Guidelines on Notification of Selected Household/Urban Hazardous Substance (HUHS) Products |
| 23 October 2013 | FDA Memorandum Circular No.2013-044 | Warning on Toxic Enantiomer Levomethorphan Contaminated API Dextromethorphan Manufactured by Konduskar Laboratories Private Ltd., India |
| 19 September 2013 | FDA Memorandum Circular No.2013-043 | Reiteration of Policies and Guidelines on Non-Appearance, Request for change of schedule or rescheduling of dates for Registered FDA Training/Seminar Participants |
| 16 October 2013 | FDA Memorandum Circular No.2013-042 | Guidelines for Salt Manufacturers, Importers, Wholesalers, Repackers and Distributors to Ensure Adequate Iodization of Iodized Salt, and for Other Purposes |
| 24 September 2013 | FDA Memorandum Circular No.2013-040 | Guidelines for the Exercise by the FDA of Its Power to Accept Donations |
| 2 September 2013 | FDA Memorandum Circular No.2013-039 | Amendment of FDA Memorandum Circular No. 2013-016 dated 02 May 2013 and FDA Memorandum Circular No. 2013-024 dated 14 June 2013, "Guidelines on Electronic Registration for Training and Seminars (E-Course Registration)" |
| 16 September 2013 | FDA Memorandum Circular No.2013-038 | Filing and Receiving of Registration and Licensing Applications |
| 12 September 2013 | FDA Memorandum Circular No.2013-037 | Application of License to Operate and Certificate of Compliance, Among other transactions, at Center for Cosmetics Regulation and Research (CCRR) From the Center for Device Regulation, Radiation Health an Research (CDRRHR)) Starting 02 January 2014 |
| 12 September 2013 | FDA Memorandum Circular No.2013-036 | Clarification on the Features of the FDA Electronic Cosmetic Product Notification (e-Notification) System |
| 10 September 2013 | FDA Memorandum Circular No.2013-035 | Six (6) Months Moratorium on the Requirement of Certificate of Product Registration for Raw Materials to be Presented or Submitted to the Bureau of Customs Prior to Release, as per FDA Memorandum Circular 2013-032, Dated 28 August 2013 |
| 3 September 2013 | FDA Memorandum Circular No.2013-034 | Submissions of Samples of Food Products for Registration Purposes |
| FDA Memorandum Circular No.2013-033-A | Amendment of Procedure of Payment and Operating Hours of FDA Cashier | |
| 2 September 2013 | FDA Memorandum Circular No.2013-033 | Receiving of Applications and Payment of FDA Fees and Charges |
| 28 August 2013 | FDA Memorandum Circular No.2013-032 | Requirements for the Immediate Release of Products Covered by the FDA at the Bureau of Customs |
| 23 August 2013 | FDA Memorandum Circular No.2013-031 | Specific Policies on Schedule of Inspections, Including Policies on Means of Transportation and Meals |
| 13 August 2013 | FDA Memorandum Circular No.2013-030 | Guidelines on the Use of the FDA Logo and Name in Promotional, Advertisement, Sponsorship, Marketing or Commercial Materials |
| 22 July 2013 | FDA Memorandum Circular No.2013-029 | Fair and Equal Treatment To All FDA Clients, Consumers and Other Stakeholders |
| 05 July 2013 | FDA Memorandum Circular No.2013-028 | General Guidelines on the Promo Permit Applications and Other Purposes |
| 14 June 2013 | FDA Memorandum Circular No.2013-025 | Transfer of Advertisement and Promotion Functions from the Legal Services Support Center to the Other Centers of FDA |
| 14 June 2013 | FDA Memorandum Circular No.2013-024 | Amendment to FDA Memorandum Circular No. 2013-016 "Guidelines on Electronic Registration for Training and Seminars (E-Course Registration)" |
| 06 June 2013 | FDA Memorandum Circular No.2013-023 | Conversions to Electronic Copy of All Registered Drug Products Dossier |
| 07 June 2013 | FDA Memorandum Circular No.2013-022 | Batch Assessment of Electronic Cosmetic Product Notification (e-Notification) |
| 24 May 2013 | FDA Memorandum Circular No.2013-021 | Receiving of Applications (Food, Drug, Cosmetic and Household Hazardous Substances Establishments under the Regional Field Office-National Capital Region( RFO-NCR)) |
| 10 May 2013 | FDA Memorandum Circular No.2013-019 | Decking Schedule of Drug Product Registration Applications |
| 29 April 2013 | FDA Memorandum Circular No.2013-018 | Guidelines for Payment at the Cashier Section |
| 03 May 2013 | FDA Memorandum Circular No.2013-017 | Validation and Certification of Registered Products and License to Operate |
| 02 May 2013 | FDA Memorandum Circular No.2013-016 | Guidelines on Electronic Registration for Training and Seminars (E-Course Registration) |
| 30 April 2013 | FDA Memorandum Circular No.2013-015 | Guidelines for Bank Payment of Electronic Cosmetic Product Notification (E-Notification) |
| 25 April 2013 | FDA Memorandum Circular No.2013-014 | Follow-Up of Applications |
| 8 April 2013 | FDA Memorandum Circular No.2013-013 | Guidelines in the Conduct of the "Kapihan at Talakayan sa FDA" |
| 8 April 2013 | FDA Memorandum Circular No.2013-012 | Revised Policies on the Application for Automatic Renewal of Certificate of Product Registration ( CPR) for Medical Devices excluding In-Vitro Diagnostic Products |
| 21 March 2013 | FDA Memorandum Circular No.2013-011-A | Amendment to FDA Memorandum Circular No. 2013-11 Re: Electronic Cosmetic Product Notification (E-Notification) |
| 15 March 2013 | FDA Memorandum Circular No.2013-011 | Electronic Cosmetic Product Notification (E-Notification) |
| 12 March 2013 | FDA Memorandum Circular No.2013-010 | Release of Hardcopy Application for License to Operate (LTO) and Certificate of Product Registration (CPR) |
| 24 February 2013 | FDA Memorandum Circular No.2013-009 | LTO Application for Medical Devices |
| FDA Memorandum Circular No.2013-008 | List of Companies with Valid Certificate of Health Related Devices Registration (CHRDR) for their Water Purification Device/System and List of Companies with Expired CHRDR for their Water Purification Device/System | |
| 22 February 2013 | FDA Memorandum Circular No.2013-007 | Schedule of Receiving and Releasing of Food Applications |
| 15 February 2013 | FDA Memorandum Circular No.2013-006-A | Amendment to FDA Memorandum Circular No. 2013-006 dated 08 February 2013 entitled "Receiving of Applications" |
| 08 February 2013 | FDA Memorandum Circular No.2013-006 | Receiving of Applications |
| 08 February 2013 | FDA Memorandum Circular No.2013-005 | License To Operate (LTO) Data |
| 04 February 2013 | FDA Memorandum Circular No.2013-004 | Qualified Person in Industry (Food, Drug, Cosmetic and Device ) Regulatory Affairs (QPIRA) Training-Accreditation Guidelines |
| 22 February 2013 | FDA Memorandum Circular No.2013-001-A | Amendment - Memorandum Circular No. 2013-001 Re: Submission of Application for License to Operate (LTO) and Certificate of Product Registration (CPR) with Electronic Copy (E-Copy) |
| 02 January 2013 | FDA Memorandum Circular No.2013-001 | Guidelines on the Submission of LTO and CPR Application with Electronic Copy (E-Copy) • LTO and CPR App Process Flowchart • ANNEX 1 ECOMMERCE LAW • ANNEX 2 CHECKLIST FOR LTO • ANNEX 4 AFFIDAVIT |
| 25 June 2015 | FDA Memorandum Circular No. 2015-008 | Policy and Requirements for Availing of Compassionate Special Permit for Registrable Medical Devices |
| 17 June 2015 | FDA Memorandum Circular No. 2015-007 | Mode of Payment for Batch Notification |
| 05 June 2015 | FDA Memorandum Circular No. 2015-006 | Release of Imported Household/Urban Hazardous Substances (HUHS) Finished Products from the Bureau of Customs (BOC) Intended Solely for Own Consumption |
| 04 June 2015 | FDA Memorandum Circular No. 2015-005 | Reiteration to Procure Drug Products from FDA-Licensed Marketing Authorization Holders (MAH) |
| 17 February 2015 | FDA Memorandum Circular No. 2015-004 | Revised FDA Citizen's Charter |
| 06 February 2015 | FDA Memorandum Circular No. 2015-003 | Reiteration of the FDA Requirement for the Change in the Use of the Message/Phrase "No Approved Therapeutic Claim" in Filipino as: "Mahalagang Paalala: Ang (Name of Product) ay Hindi Gamot at Hindi Dapat Gamiting Panggamot sa Anumang Uri ng Sakit" in all Advertisements, Promotional, and/or Sponsorship Activities or Materials. |
| 13 April 2018 | FDA Memorandum Circular No. 2018-001 | Period of Payment of e-Portal Applications |
| 22 July 2019 | FDA Memorandum Circular No. 2019-005 | Pilot Study on the Implementation of DOH AO 2018-0002 re_ Guidelines Governing the Issuance of an Authorization for a Medical Device Based on the ASEAN Harmonized Technical Requirements |
| 25 July 2016 | FDA Memorandum Circular No. 2016-004 | Reiterating DOH Department Memorandum No. 2016-0239 Regarding "Removal of Selected DOH IEC Materials" dated 14 July 2016 |
| 19 July 2017 | FDA Memorandum Circular No. 2017-003 | Collection Policy and Procedure |
| 19 July 2017 | FDA Memorandum Circular No. 2017-002 | 1st Food and Drug Administration (FDA) Regulatory Advocacy Fair and Back-to-back Qualified Person in the Industry Regulatory Affairs (QPIRA) Trainings |
| 17 November 1986 | Bureau Circular No. 2 s. 1986 | Assignment of Brand Name and /or Generic Name for a Formulation of a Drug or Pharmaceutical Specialty |
| 28 June 1991 | Bureau Circular No. 12 s. 1991 | Clarification of New Registration when there is a Change of Manufacturer |
| 16 September 1994 | Bureau Circular No. 23 s. 1994 | Amending Memo Circular No. 4 s. 1994: Compliance with IRR of Senior Citizen Act |
| 18 November 1994 | Bureau Circular No. 2 s. 1994 | Amendment of MC No. 4 s. 1994 |
| 17 October 1995 | Bureau Circular No. 4 s. 1995 | Period within an Initial Conditional Registration shall be Processed and Issued |
| 9 October 1995 | Bureau Circular No. 3-A s. 1995 | Revised and /or Updated Lists of Ingredients or Substances in Cosmetics Recommended after a Series of Review and Studies by the BFAD-Industry Joint Study Group |
| 16 February 1995 | Bureau Circular No. 1 s. 1995 | Phase-out of Potassium Bromate as Flour Treatment in Bread-Making |
| 14 May 1998 | Bureau Circular No. 03 s. 1998 | Upgrading of Manufacturing Facilities in Consonance with CGMP Requirements Beginning 1996 Up to Year-End 1999 |
| 3 August 1998 | Bureau Circular No. 05 s. 1998 | Extension of the Validity Period of Renewal Registration of Medical and Dental Devices |
| 23 October 1998 | Bureau Circular No. 07 s. 1998 | Adoption of the Guiding Principles for Good Manufacturing Practice (GMP) Guidelines in the Manufacture of Cosmetic Products |
| 13 April 1999 | Bureau Circular No. 08 s. 1998 | Upgrading of Manufacturing Facilities in Consonance with CGMP Requirements Beginning 1996 Up to Year-End 1999 |
| 07 August 1996 | Bureau Circular No. 05 s. 1996 | Iterating Article IV, Section 25 of Republic Act 5921 |
| 30 July 1996 | Bureau Circular No. 04 s. 1996 | Pertinent Provisions of Republic Act (RA) 7581 otherwise Known as the Price Act |
| 22 April 1996 | Bureau Circular No. 03 s. 1996 | Selling of Drugs or Medicines to the Public |
| 11 April 1996 | Bureau Circular No. 02 s. 1996 | Ban Against Importation of UK Beef and Beef Products Effective Immediately |
| 05 September 1997 | Bureau Circular No. 13 s. 1997 | The Advertising and Promotions Agencies Manufacturers and Distributors of Processed Food, Drugs, Devices, Cosmetics, and Household Hazardous Substances, other Parties Concerned |
| 04 September 1997 | Bureau Circular No. 12 s. 1997 | 1997 Updated Listing of Cosmetic Ingredients |
| 02 September 1997 | Bureau Circular No. 11 s. 1997 | Extension of the Period to Declare Unregistered Imported Food Products Under Bureau Circular No. 4 s. 1997 |
| 10 July 0199 | Bureau Circular No. 09 s. 1997 | Specific Guidelines for Preparation of Order of Payment and Collection of Fees for Certificate of Authentication for Copies of BFAD Official Document(s) |
| 30 April 1997 | Bureau Circular No. 08 s. 1997 | Implementation Details of BFAD Circular No. 1 s. 1997 |
| 31 March 1997 | Bureau Circular No. 06 s. 1997 | Extension of the Period to Declare Unregistered Imported Food Products Under Bureau Circular No. 4 s. 1997 |
| 19 March 1997 | Bureau Circular No. 05 s. 1997 | Revised Checklist of Requirements and the 1997 Guidelines for the Registration of Pharmaceutical Products |
| 03 February 1997 | Bureau Circular No. 03 s. 1997 | Guidelines for the Processing of Requests for Authentication for Copies of BFAD Official Documents by Parties other than the Department of Health or any of its Agencies |
| 04 February 1997 | Bureau Circular No. 02 s. 1997 | Accreditation of Drug Liaison Officers |
| 21 January 1997 | Bureau Circular No. 1 s. 1997 | For Registration of Products Included in the List B' (Prime) Under DOH-Administrative Order No. 67 Series of 1989 |
| 18 January 2002 | Bureau Circular No. 01 s. 2002 | Notarized Application Forms for Product Registration |
| 22 January 2002 | Bureau Circular No. 02 s. 2002 | Setting the Deadline for the Compliance with Bureau Circular No. 16-A s. 2001 on the Labelling and Advertisement of Cigarettes |
| 31 January 2002 | Bureau Circular No. 03 s. 2002 | Reclassification of Sambong 250 mg Tablet from Over-The-Counter (OTC) to Household Remedy |
| 04 April 2002 | Bureau Circular No. 05 s. 2002 | Extension of the Validity Period of Initial and Renewal Registration of In-vitro Diagnostic Reagents/Kits |
| 04 April 2002 | Bureau Circular No. 06 s. 2002 | Amending Bureau Circular No. 02 s. 2002 setting the Deadline for Compliance on the Labeling and Advertisement of Cigarettes Mandated under DOH-Administrative Order No. 10 s. 1993 and Bureau Circular No. 16-A s. 2001 |
| 29 April 2002 | Bureau Circular No. 07 s. 2002 | Upgrading of Manufacturing Facilities in Harmony with AO No. 90 s. 2002, Current Good Manufacturing Practice (cGMP) Guidelines for Cosmetic Products |
| 25 October 2002 | Bureau Circular No. 08 s. 2002 | Guidelines for Monitoring Iodized Salt |
| 15 August 2002 | Bureau Circular No. 09 s. 2002 | Customs Memorandum Circular No. 218-2000 Dated 18 July 2002 |
| 11 September 2002 | Bureau Circular No. 10 s. 2002 | Revised List of Permissible Cosmetics Claims that Require Justification |
| 03 October 2002 | Bureau Circular No. 11 s. 2002 | Site Information File (SIF) |
| 25 October 2002 | Bureau Circular No. 12 s. 2002 | Reiterating the Ban on the Use of Chloramphenicol in Food Producing Animals |
| 25 October 2002 | Bureau Circular No. 13 s. 2002 | The Field Test Kits for Iodated Salt |
| 24 November 1999 | Bureau Circular No. 23 s. 1999 | Exfoliant and Exfoliate as Permissible Claims for Cosmetic Preparations |
| 27 October 1999 | Bureau Circular No. 22 s. 1999 | Deletion of the Requirement for a Certificate of Brand Name Clearance in Filing an Application for Registration of Branded Products |
| 27 October 1999 | Bureau Circular No. 21 s. 1999 | Guidelines for the Evaluation of Brand Names for Products to be Registered with the Bureau of Food and Drugs |
| Bureau Circular No. 19 s. 1999 | Re-Iterating Section 20(b)(1)(B) of RA 3720 as Amended by Section 12 of EO 175 and Section 29-a of EO 175 | |
| 16 August 1999 | Bureau Circular No. 18 s. 1999 | Importation and Registration of Imported Pre-Packed Food Products |
| 23 July 1999 | Bureau Circular No. 17-A s. 1999 | Resumption of Acceptance of Application for Registration of Branded Ethical/Prescription Pharmaceutical Products |
| 23 July 1999 | Bureau Circular No. 17 s. 1999 | Transfer of Processing of Brand Name Clearance for Pharmaceutical Products to the Intellectual Property Office (IPO) |
| 06 January 1999 | Bureau Circular No. 16 s. 1999 | Amending BFAD MC #22 Dated September 8, 1994 Regarding Inventory, Proper Disposal and/or Destruction of Used Vials or Bottles |
| 14 June 1999 | Bureau Circular No. 13-A s. 1999 | Moratorium on the Conduct of Bioavailability/Bioequivalence Studies for Pharmaceutical Products |
| 11 June 1999 | Bureau Circular No. 12-B s. 1999 | Phasing-Out the Registration of Branded Version of Registered Unbranded Drug Product and Unbranded Version of Registered Branded Drug Product (Memorandum Circular No. 10-A s. 1992) |
| 01 June 1999 | Bureau Circular No. 11 s. 1999 | Certification of Registrations' Annotation of Suspension/Cancellation of Drug or Drug Product Combination Found to be Adulterated/Misbranded |
| 22 April 1999 | Bureau Circular No. 9 s. 1999 | Labeling of Prepackaged Processed Meat Products |
| Bureau Circular No. 8-A s. 1999 | Guidelines in the Collection and Submission of Samples of Food, Drugs, Cosmetics, and Medical Devices for Physico-Chemical Analysis | |
| 13 April 1999 | Bureau Circular No. 8s. 1999 | Amendment to Bureau Circular No. 8 s. 1998 Registration of Imported Food Products Covered by an Exclusive Distributorship Agreement; and Sale or Offer for Sale of the same Products whose Registration Papers are still In-Process |
| 18 February 1999 | Bureau Circular No. 7 s. 1999 | Re-Iterating Article IV, Section 30 of Republic Act 5921 |
| 15 February 1999 | Bureau Circular No. 6 s. 1999 | Revised Bureau Circular No. 4 s. 1999 New Protocol for Registration of Drugs, Foods, Cosmetics and Medical Devices |
| 10 February 1999 | Bureau Circular No. 05 s. 1999 | Revised Process of Submission of Application for Product Registration |
| 14 June 2000 | Bureau Circular No. 4 s. 2000 | Implementation of Administrative Order No. 13, s. 1999, "Use of Hydroquinone and/or Tretinoin (Retinoic Acid) |
| 08 June 2000 | Bureau Circular No. 3-A s. 2000 | Amendment to FDA Circular No. 2 s. of 1982 on the Importation of Semi-Synthetic Antibiotics |
| 28 February 2000 | Bureau Circular No. 3 s. 2000 | Submission of Test Procedures and Test Specifications for Products to be Included in the Philippine Pharmacopeia |
| 24 January 2000 | Bureau Circular No. 2 s. 2000 | Submission of List of All Pending Applications for Registration/Listing of Cosmetic Products and Household Hazardous Substances |
| 13 January 2000 | Bureau Circular No. 1 s. 2000 | Moratorium on the Acceptance of Application for Initial Registration of Pharmaceutical Products |
| 7 December 2001 | Bureau Circular No. 18 s. 2001 | Delisting of Levonorgestrel 750 mcg (Postinor) from Bureau of Food and Drugs Registry of Drug Products |
| 21 November 2001 | Bureau Circular No. 17 s. 2001 | In answer to queries on the classification of the products listed below, the Office of the Director issues this Bureau Circular for all those concerned. Please be advised that the classification of the following products |
| 20 November 2001 | Bureau Circular No. 16-A s. 2001 | Labelling and Advertisement of Cigarettes |
| 20 November 2001 | Bureau Circular No. 16 s. 2001 | Guidelines for the Immediate Processing of Applications for Initial Registration of Pharmaceutical Products |
| November 13, 2001 | Bureau Circular No. 15-A s. 2001 | Amendment to BFAD Circular No. 23 Dated 16 September 1994 |
| October 26, 2001 | Bureau Circular No. 15 s. 2001 | Guidelines for the Immediate Processing of Pending Applications for Renewal Registration of Pharmaceutical Products |
| October 26, 2001 | Bureau Circular No. 14 s. 2001 | Amendment to Bureau Circular No. 13-A s. 2001 "Over-the-Counter (OTC) Drugs Reclassified as Household Remedies" |
| October 17, 2001 | Bureau Circular No. 13-A s. 2001 | Amendment to Bureau Circular No. 11 s. 2001 "Over-the-Counter (OTC) Drugs Reclassified as Household Remedies" |
| October 17, 2001 | Bureau Circular No. 13 s. 2001 | Erratum to Bureau Circular No. 9 s. 2001 |
| October 5, 2001 | Bureau Circular No. 12 s. 2001 | Addendum to Bureau Circular No. 6-A s. 2001 Dated June 11, 2001 |
| August 20, 2001 | Bureau Circular No. 11 s. 2001 | Over-the-Counter (OTC) Drugs Reclassified as Household Remedies |
| August 10, 2001 | Bureau Circular No. 10 s. 2001 | Submission of Site Information File and Updating |
| August 7, 2001 | Bureau Circular No. 09 s. 2001 | Glass Ionomers of Atraumatic Restorative Treatment (ART), Fit and Fissure Sealant, Hand Instruments with Kits for ART |
| 6 July 2001 | Bureau Circular No. 08 s. 2001 | Guidelines to be Observed on the Implementation of Product Recall System |
| 22 June 2001 | Bureau Circular No. 07 s. 2001 | Proposed Guidelines for the Assessment of Microbiological Quality of Processed Foods |
| 11 June 2001 | Bureau Circular No. 06-A s. 2001 | Revised Minimum Required Samples for Laboratory Analysis |
| 30 May 2001 | Bureau Circular No. 06 s. 2001 | Aflatoxin M1 in Milk |
| 30 May 2001 | Bureau Circular No. 05 s. 2001 | Acute Toxicity of Tin |
| 20 April 2001 | Bureau Circular No. 04 s. 2001 | Extension of the Validity of Monitored Release Study |
| 5 April 2001 | Bureau Circular No. 03 s. 2001 | Cancellation of the Certificates of Product Registration, Seizure and Confiscation of BFAD registered products, which do not conform to their registered specifications |
| 8 March 2001 | Bureau Circular No. 02 s. 2001 | Advisory on Voluntary Recall of Processed Meat Products Imported from European Countries |
| 8 March 2001 | Bureau Circular No. 01 s. 2001 | Guidelines on the Temporary Ban on the Importation of Processed Meat Products from Cattle, Sheep and Goat, and other Food Ingredients Containing Substances Derived from these Animals |
| 10 April 2003 | Bureau Circular No. 05-B s. 2003 | Attendance in Licensing Seminar as a Requirement in the Application for a License to Operate of a Drug Establishment / Drug Outlet (AO 56 s. 1989) |
| 10 April 2003 | Bureau Circular No. 05 s. 2003 | Classification of Hemodialysis Products as Drugs |
| 17 March 2003 | Bureau Circular No. 03-A s. 2003 | Mandatory Dissemination of Information Regarding the Precaution/Warning of Drug Products Containing Phenylpropanolamine (PPA) |
| 17 March 2003 | Bureau Circular No. 03 s. 2003 | Mandatory Printing of Boxed Warning on All Phenylpropanolamine (PPA) Containing Products (OTC and RX) |
| 13 February 2003 | Bureau Circular No. 02 s. 2003 | Classification of Paracetamol Syrup/Suspension 120 mg/5mL and 125 mg/5mL |
| 04 January 2005 | Bureau Circular No. 01 s. 2005 | Classification of All Injectable Hyaluronic Acid as Device |
| 19 January 2005 | Bureau Circular No. 03s. 2005 | Submission of Site Information File |
| 03 January 2005 | Bureau Circular No. 05 s. 2005 | Black Box Warning for all Antidepressant Drugs |
| 10 February 2005 | Bureau Circular No. 06 s. 2005 | List of Recognized Laboratories |
| 04 April 2005 | Bureau Circular No. 08 s. 2005 | Selective COX-2 Inhibitors |
| 07 April 2005 | Bureau Circular No. 09 s. 2005 | Submission of Site Information File |
| 07 June 2005 | Bureau Circular No. 11 s. 2005 | Revised Labeling of Selective COX-2 Inhibitor Drugs and NSAIDS |
| 22 June 2005 | Bureau Circular No. 12 s. 2005 | BFAD Quality Seal |
| 22 June 2004 | Bureau Circular No. 13 s. 2005 | Submission of Site Information File (SIF) |
| 29 June 2005 | Bureau Circular No. 13-A s. 2005 | Reconstitution of the BFAD-Cosmetics Industry Joint Committee |
| 06 July 2005 | Bureau Circular No. 14 s. 2005 | Gene Therapy |
| 14 July 2005 | Bureau Circular No. 18 s. 2005 | New Advisory on Labeling Selective Cycloxygenase-2 (COX-2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) |
| 21 October 2005 | Bureau Circular No. 19 s. 2005 | Extension of Submission of Site Information File (SIF) |
| 24 October 2005 | Bureau Circular No. 20 s. 2005 | Revised Assessment Slips |
| 11 November 2005 | Bureau Circular No. 21 s. 2005 | Cut-Off Time for the Receiving of Payments of Fees in BFAD |
| 13 December 2004 | Bureau Circular No. 20 s. 2004 | Submission of Application for Registration in Accordance with the Asean Common Technical Document (ACTD) Format |
| 26 November 2004 | Bureau Circular No. 19 s. 2004 | Delisting of Rofecoxib from Bureau of Food and Drugs Registry of Drug Products |
| 17 November 2004 | Bureau Circular No. 18 s. 2004 | Mandating the Use of Vitamin A and Iron Fortified Flour |
| 12 October 2004 | Bureau Circular No. 14 s. 2004 | Submission of Adverse Drug Reaction Reports on COX-2 Inhibitors as Part of Safety Monitoring |
| 27 September 2004 | Bureau Circular No. 13 s. 2004 | Clarification of Par. a, Bureau Circular No. 6 s. 1999 (Revised BC No. 4 s. 1999 "New Protocol for Registration of Drugs, Foods, Cosmetics and Medical Devices") |
| 14 September 2004 | Bureau Circular No. 12 s. 2004 | Entry of Meat-Based Food Products into the EU |
| 2 August 2004 | Bureau Circular No. 11 s. 2004 | Food and Drugs (Composition and Labeling Amendment) Regulation 2004 Issued by Hongkong Food and Environmental Hygiene Department |
| 27 July 2004 | Bureau Circular No. 10 s. 2004 | Information on the Exportation of Fresh/Frozen Marine Products and Fresh, Frozen and Chilled Chicken Meat from the Philippines |
| 1 July 2004 | Bureau Circular No. 09 s. 2004 | Articles Regarding the Bioterrorism Act Published/Released by the US Food and Drug Administration |
| 10 June 2004 | Bureau Circular No. 08 s. 2004 | Regulation and Monitoring of the Mandatory Fortification of Staples (Rice, Sugar, Flour and Cooking Oil) and their Utilization by Food Processors as Ingredients |
| 3 June 2004 | Bureau Circular No. 07 s. 2004 | Registration of Veterinary Products |
| 18 May 2004 | Bureau Circular No. 06 s. 2004 | Office of the President Memorandum Order No. 136: Approving the 2004 Investment Priorities Plan |
| 06 April 2004 | Bureau Circular No. 05 s. 2004 | Consolidation and Updates of Permissible Cosmetic Claims |
| 3 April 2004 | Bureau Circular No. 04-B s. 2004 | Whitening Agents in Cosmetics Preparations |
| 30 March 2004 | Bureau Circular No. 04-A s. 2004 | Different Brand names for narcotic/Opioid Analgesic Drugs for Cancer Pain |
| 30 March 2004 | Bureau Circular No. 04 s. 2004 | Reiterating Memorandum Circular No. 008 s. 1988 (Re: Drug and Medical Device Registration) |
| 26 March 2004 | Bureau Circular No. 03 s. 2004 | Guidelines for the Registration and Performance Validation of Methamphetamine (MET)/Tetrahydrocannabinol (THC) Drug Screening Test Kits |
| 04 February 2004 | Bureau Circular No. 01-A s. 2004 | Guidelines for the Assessment of Microbiological Quality of Processed Foods |
| 08 January 2004 | Bureau Circular No. 01 s. 2004 | Sale of BFAD: ICR Mice and BFAD: SD Rat |
| 18 December 2006 | Bureau Circular No. 2006-017 | Amendment to Bureau Circular 2006-001 Updated Guidelines for the Submission of Application for Notification, Registration and Export of Cosmetic Products |
| 18 October 2006 | Bureau Circular No. 2006-015 | Guidelines for the Issuance of a Conditional Certificate of Product Registration for Veterinary Products with Initial Registration with the Bureau of Food and Drugs |
| 04 October 2006 | Bureau Circular No. 2006-014 | Licensing of Veterinary Establishments |
| 05 September 2006 | Bureau Circular No. 2006-013 | Amendment to Bureau Circular No. 17 s. 2005 further Updating the Accepted Whitening Agents for Cosmetics |
| 04 September 2006 | Bureau Circular No. 2006-012 | Maximum Allowable Limits of Heavy Metals for Cosmetic Products |
| 19 June 2006 | Bureau Circular No. 10 s. 2006 | Good Manufacturing Practice Seminar for Food Establishments Based on AO 153 s. 2004 and Other Related Regulations |
| 22 May 2006 | Bureau Circular No. 09 s. 2006 | Amendment to Bureau Circular No. 06. s. 2005 - List of Recognized Laboratories |
| 08 October 2007 | Bureau Circular No. 2006-008-A | Amendment to Bureau Circular No. 008 s. 2006, The Subject of which is the Lifting of Moratorium on the Conduct of Bioavailability/Bioequivalence Studies for Selected Pharmaceutical Products and Bureau Circular No. 2007-005 or the Supplemental Guidelines for the Processing of Principal Certificate of Product Registration and Providing for the Procedures and/or Guidelines thereof |
| 27 April 2006 | Bureau Circular No. 08 s. 2006 | Lifting of Moratorium on the Conduct of Bioavailability / Bioequivalence Studies for Selected Pharmaceutical Products |
| 28 February 2006 | Bureau Circular No. 06 s. 2006 | Creation of BFAD Food Fortification Data Management System Team |
| 22 February 2006 | Bureau Circular No. 05 s. 2006 | Guidelines for the Submission of Application for Automatic Renewal Registration of Pharmaceutical Products, Medical Devices , Prepackaged Food and Food Products, and Household Hazardous Substances |
| 28 February 2006 | Bureau Circular No. 04 s. 2006 | Mandatory Fortification of Flour |
| 10 February 2006 | Bureau Circular No. 03 s. 2006 | Mandatory Attendance to the Cosmetic Seminar Covering the 13 ASEAN Training Modules on Good Manufacturing Practice |
| 09 February 2006 | Bureau Circular No. 02 s. 2006 | Implementation of Bureau of Food and Drugs Quality Seal Program in Line with the FOURmula One for Health Initiative |
| 03 January 2006 | Bureau Circular No. 01 s. 2006 | Updated Guidelines for the Submission of Application for Notification, Registration and Export of Cosmetic Products |
| 29 January 2007 | Bureau Circular No. 2007-001 | Mandatory Submission of List Products Being Handled |
| 27 February 2007 | Bureau Circular No. 2007-004 | Guidelines for the Implementation of Administrative Order No. 2007-006 (Amendment to Administrative Order No. 46 s. 1988 Re: Organizational Arrangements to Implement the National Drug Policy) |
| 2 April 2007 | Bureau Circular No. 2007-005 | Supplemental Guidelines for the Processing of Principal Certificate of Product Registration (CPR) |
| 12 July 2007 | Bureau Circular No. 2007-006 | Additional Requirement for Importation of Processed Food Products for Distribution in the Philippines |
| 24 March 2008 | Bureau Circular No. 2007-006-A | Amendment to Bureau Circular No. 2007-006 Providing for the Additional Requirement for Importation of Processed Food Products for Distribution in the Philippines |
| 27 July 2007 | Bureau Circular No. 2007-007 | Products Imported from China |
| 10 October 2007 | Bureau Circular No. 2007-009 | Updated Standards for Iodine Level of Salts |
| 10 October 2007 | Bureau Circular No. 2007-009 | Updated Standards for Iodine Level of Salts |
| 1 October 2007 | Bureau Circular No. 2007-011 | Adoption of the Association of Southeast Asian Nations Common Technical Documents (ACTD) and Common Technical Requirements (ACTR) on the Pharmaceutical Product Registration for Human Use |
| 21 December 2007 | Bureau Circular No. 2007-013 | Updated Guidelines for the Implementation of the Association of South East Asian Nation (ASEAN) Cosmetic Directive and the Association of South East Asian Nation (ASEAN) Common Technical Documents |
| 21 January 2008 | Bureau Circular No. 2007-013-A | Amendment to Bureau Circular No. 2007-013 Updated Guidelines for the Implementation of the Association of South East Asian Nation (ASEAN) Cosmetic Directive and the Association of South East Asian Nation (ASEAN) Common Technical Documents |
| 08 January 2020 | Administrative Order No. 2020-0001 | Guidelines in the Importation, Facilitation and Management of Foreign Donations involving Health and Health-Related Products |
| 09 December 2008 | Bureau Circular No. 2008-005 | Grace Period for the 3rd Updates and Amendments of the ASEAN Cosmetic Directive (ACD) |
| 29 September 2008 | Bureau Circular No. 2008-004 | Testing of Infant Formula and Other Milk Product for the Presence of Melamine • Partial List of Milk and Other Milk Products Collected by BFAD for Testing for the Presence of Melamine • Updated Partial List of Milk and Other Milk Products Collected by BFAD for Testing for the Presence of Melamine as of 29 September 2008 |
| 07 August 2008 | Bureau Circular No. 2008-003 | Grace Period for the 2nd Updates and Amendments of the ASEAN Cosmetic Directive (ACD) |
| 10 June 2008 | Bureau Circular No. 2008-002 | Seminar Fees for the Participants of Seminars on Licensing of Establishments and Product Registration |
| 02 May 2008 | Bureau Circular No. 2008-001 | Grace Period for the New Updates and Amendments of the ASEAN Cosmetic Directive (ACD) |
| 15 August 2010 | FDA Circular No.2010-018 | New Price of ASEAN Reference Substances (ARS) |
| 04 October 2010 | FDA Circular No.2010-017 | Uploading of All Data for the Electronic Essential Drug Price Monitoring System (e-EDPMS) |
| 15 October 2010 | FDA Circular No.2010-016-A | Amending FDA Circular No. 2010-016 Dated 20 September 2010 by Declaring Additional Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize from Public Sale and Distribution such P |
| 20 September 2010 | FDA Circular No.2010-016 | Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous |
| 21 August 2010 | FDA Circular No.2010-015 | Declaring the Identified Products to be Imminently Injurious Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Product from Public Sale or Distribution |
| 12 August 2010 | FDA Circular No.2010-014 | Updates and Amendments of ASEAN Cosmetic Directive (ACD) |
| 02 August 2010 | FDA Circular No.2010-013 | Revised Notification Template for Cosmetic Products |
| 08 July 2010 | FDA Circular No.2010-012 | Republic Act No. 9442 and Its Implementing Rules and Regulations |
| 16 June 2010 | FDA Circular No.2010-011 | Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution |
| 2 April 2012 | FDA Circular No.2010-010-A | Amendment to FDA Circular No. 2010 Dated 24 May 2010 Cut-Off Time for Receiving of Applications and Payment of Fees in FDA |
| 24 May 2010 | FDA Circular No.2010-010 | Cut-Off Time for Receiving of Applications and Payments of Fees in FDA |
| 16 April 2010 | FDA Circular No.2010-009 | Amendment to Memorandum Circular No. 5 s. 1994 Dated April 20, 1994 Regarding Report on Adverse Drug Reaction |
| 29 March 2010 | FDA Circular No.2010-008 | Adoption of the CODEX Standards on Food Contaminants in Processed Food |
| 15 March 2010 | FDA Circular No.2010-007 | Automatic Renewal of License to Operate (LTO) |
| 09 March 2010 | FDA Circular No.2010-006 | Automatic Revalidation of License to Operate (LTO) |
| 17 February 2010 | FDA Circular No.2010-005 | Submission of Process Flow in Handling Adverse Events from Drugs, Medical Devices, Food Supplements, Milk Products, Herbals, etc. |
| 18 February 2010 | FDA Circular No.2010-004 | Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution |
| 20 January 2010 | FDA Circular No.2010-003 | Revised Fees for Seminar on Licensing of Drug Establishments |
| 08 January 2010 | FDA Circular No.2010-002 | Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution |
| 08 January 2010 | FDA Circular No.2010-001 | Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution |
| 19 January 2009 | Bureau Circular No. 2009-002 | Specific Operational Instructions Implementing Administrative Order No. 2008-0033 Dated December 2, 2008, Subject: Rules and Conditions in Exempting Antibiotic Drug Products from the Batch Certification Requirement Amending for this Purpose Item III (C) and (D) of Administrative Order No. 103 s. 2002 "Batch Certification of Antibiotics", and for Other Purposes. |
| 02 July 2009 | Bureau Circular No. 2009-003 | Grace Period for the 4th Updates and Amendments of the ASEAN Cosmetic Directive (ACD) |
| Bureau Circular No. 2009-004 | End Dates in the Importation and Distribution of Metered Dose Inhalers Containing Chlorofluorocarbon (CFC) | |
| 08 February 2012 | FDA Circular No. 2012-001 | New Pharmacist Form |
| 15 February 2012 | FDA Circular No. 2012-002 | Dishonored Checks |
| 21 February 2012 | FDA Circular No. 2012-003 | Declaring Unregistered Slimming Products to be Imminently Injurious, Unsafe or Dangerous and Ordering the Recall, Ban or Seizure from Public Sale or Distribution |
| 20 April 2012 | FDA Circular No. 2012-004 | Express Lane for Payment of FDA Fees and Charges |
| 02 June 2012 | FDA Circular No. 2012-007 | Recognition of Ethical Review Board/Committee (ERB/ERC) for Purposes of the Conduct of Clinical Trials on Investigational Medicinal Products in the Philippines and for Other Purposes |
| 24 May 2019 | FDA Circular No. 2012-007-A | Reduction of Turn-Around-Time for the Regulatory Review of Clinical Trials and Revised Procedure for the Application of Import License for Investigational Products |
| 30 July 2012 | FDA Circular No. 2012-008 | Licensing and Registration Seminar for Food Establishments |
| 03 September 2012 | FDA Circular No. 2012-009 | Declaring the Below Identified Additional Cosmetic Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize the Products Listed Therein from Public Sale or Distribution |
| 05 September 2012 | FDA Circular No. 2012-011 | Authority of FDA Inspectors |
| 05 September 2012 | FDA Circular No. 2012-012 | Guidelines for Handling Rapid Alerts Arising from Quality Defects |
| 16 August 2012 | FDA Circular No. 2012-014 | Disposition of Flood-Affected Health Products |
| 7 July 2011 | FDA Circular No. 2011-003-A | Revision to the Schedule of Fees Listed in FDA Circular No. 2011-003 Dated 24 June 2011 on the Collection of Legal Research Fee Imposed by Republic Act No. 3870, as Amended by PD 200 and Further by PD 1856 |
| 24 June 2011 | FDA Circular No. 2011-003 | Collection of Legal Research Fee Imposed by Republic Act No. 3870, as Amended by PD 200 and Further Amended by PD 1856 |
| 02 June 2011 | FDA Circular No. 2011-002 | Application for Revision/Updates in the Package Insert, Patient Leaflet Information, Prescribing Information, Core Date Sheet and Basic Succinct Statement |
| 02 May 2011 | FDA Circular No. 2011-001 | Declaring Unregistered Contact Lenses to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution |
| 05 September 2013 | FDA Circular No. 2013-024 | Adoption and Implementation of "The Mexico City Principles for Vocabulary Codes of Business Ethics in the Biopharmaceutical Sectors" • The Mexico City Principles |
| 23 August 2013 | FDA Circular No. 2013-022 | Guidelines on Handling Consumer Complaints |
| 15 August 2013 | FDA Circular No. 2013-021 | Comparator Drugs for Selected Pharmaceutical Products Containing Biopharmaceutics Classification System (BCS) Class 4 Drug Molecules |
| 13 April 2013 | FDA Circular No. 2013-020 | Reiteration of Registration of Human Cells, Tissues, and Cellular and Tissue-Based Products |
| 08 July 2013 | FDA Circular No. 2013-017 | Registration of Human Stem Cell-Based Products |
| 20 June 2013 | FDA Circular No. 2013-015 | Deregulation of Bulk Industrial Chemicals Used as Raw Materials in Cosmetic Products and Household Products Considered as Urban Hazardous Substances |
| FDA Circular No. 2013-014 | List of Product Requiring Bioequivalence (BE) Studies as Part of the Application for Marketing Authorization in Addition to Rifampicin and the 11 Products Listed in Bureau Circular No. 2006-008 | |
| 02 May 2013 | FDA Circular No. 2013-013 | Registration Amnesty for Non-Compliant Products Specifically Under Product Classification, Category IV- Do-It-Yourself and Hobby Products, Classified as Household/Urban Hazardous Substances (HUHS) |
| 15 April 2013 | FDA Circular No. 2013-012 | Validity of Generic Labeling Exemption for Pharmaceutical Products |
| 27 March 2013 | FDA Circular No. 2013-011 | Updates and Amendments of ASEAN Cosmetic Directive (ACD) • Annex II revised as per 17th ACSB • Annex III part 1revised as per 17th ACSB-1 • Annex VI revised as per 17th ACSB • Annex VII revised as per 17th ACSB |
| 16 June 2014 | FDA Circular No. 2013-009-A | Amendment to FDA Circular No. 2013-009 "Revised Guidelines in Licensing of Household Hazardous Substances (HHS) Establishments" • "CHECKLIST OF REQUIREMENTS FOR THE ISSUANCE OF LICENSE TOOPERATE FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS)ESTABLISHMENTS" • Petition Form-HHS 2013 FINAL |
| 06 March 2013 | FDA Circular No. 2013-009 | Revised Guidelines in Licensing Household Hazardous Substances (HHS) Establishments |
| 06 March 2015 | FDA Circular No. 2013-008-A | Amendment to FDA Circular No. 2013-008 on A. Process and Communication under Section IV. Details / Directive |
| 22 April 2013 | FDA Circular No. 2013-008 | Adoption of the Association of the Southeast Asian Nations (ASEAN) Post-Marketing Alert System (PMAS) for Defective or Unsafe Processed Food Products, Pharmaceutical Products, Traditional Medicines and Health Supplements, and Cosmetic and Household Hazardous Products and Devices |
| 05 March 2013 | FDA Circular No. 2013-007 | Amendment of Bureau Circular No. 2007-009 on the Standard Iodine Level of Salts for Strict Compliance of Iodized Salt Manufacturers or Processors |
| 20 March 2013 | FDA Circular No. 2013-006-A | Amendment to FDA Circular No. 2013-006 Dated 28 February 2013, "Bureau of Customs Cargo Import or Export Permits and Clearance in Electronic Form Requirement through the Philippines National Single Window" |
| 28 February 2013 | FDA Circular No. 2013-006 | Bureau of Customs Cargo Import or Export Permits and Clearance in Electronic Form Requirement Through the Philippine National Single Window |
| 19 February 2013 | FDA Circular No. 2013-005 | Training Courses and Schedule of Fees for the Training Offered by the FDA Academy - Policy Planning Office for Calendar Year 2013 |
| 22 February 2013 | FDA Circular No. 2013-004 | Post Market Surveillance (PMS) of Authorized Drug Products |
| 16 June 2014 | FDA Circular No. 2013-002-A | Amendment to FDA Circular No. 2013-002 "Revised Guidelines in Licensing of Cosmetic Establishments" • CHECKLIST OF REQUIREMENTS FOR THE ISSUANCE OF LICENSE TO OPERATE FOR COSMETIC ESTABLISHMENTS • Joint Affidavit of Undertaking-COSMETICS 2013 • Petition Form-COSMETICS 2013 FINAL • EXPLANATORY NOTES FOR INDUSTRY ON THE PREPARATION OF A SITE INFORMATION FILE |
| 04 February 2013 | FDA Circular No. 2013-002 | Revised Guidelines in Licensing Cosmetic Establishments |
| 31 January 2013 | FDA Circular No. 2013-001-A | Amendment of FDA Circular No. 2013-001 |
| 09 January 2014 | FDA Circular No. 2014-001 | Training Courses and Schedule of Fees for the Trainings Offered by The FDA Academy - Policy Planning Office for Calendar Year 2014 |
| 14 January 2014 | FDA Circular No. 2014-002 | New License to Operate Format for Drug Establishments |
| 11 February 2014 | FDA Circular No. 2014-003 | Filing and Receiving of Registration, Licensing and Other Applications Using the Integrated Application Form |
| 19 February 2014 | FDA Circular No. 2014-004 | Extension of Six-Month Moratorium on the Requirement of Certificate of Product Registration for Raw Materials to be Presented to the Bureau of Customs (BOC) Prior to Release per FDA Memorandum Circular (FMC) No. 2013-032 And FMC No. 2013-035 Until 31 August 2014 |
| 24 February 2014 | FDA Circular No. 2014-006 | Application for LTO Variation |
| 22 June 2016 | FDA Circular No. 2014-008-A | Amendment to Annex B, Notification for Minor of FDA Circular No. 2014-008 entitled "Application Process and Requirements for Post-Approval Changes of Pharmaceutical Products", Specially on Section IV, C, D, and E for Minor variation-Notification |
| 29 April 2014 | FDA Circular No. 2014-011 | Adoption of Unique Global Product Identification Number |
| 14 April 2014 | FDA Circular No. 2014-012 | Requiring Proof of Courier Service Payment for Promotion and Advertisement Permits |
| FDA Circular No. 2014-015 | Manufacture, Sale and Distribution of Traditional and Alternative Medicines | |
| 30 May 2014 | FDA Circular No. 2014-016 | Implementing Guidelines for Administrative Order No. 2013-0022 dated 13 August 2013, Subject: Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers |
| 21 July 2014 | FDA Circular No. 2014-017 | Procedure in the submission and issuance of the Food and Drug Administration Certification for Animal Feeds and Feed Products |
| 15 August 2014 | FDA Circular No. 2014-018 | Manufacture, Sale and Distribution of Unregistered Medical Grade Oxygen |
| 23 October 2014 | FDA Circular No. 2014-018-A | Amendment to FDA Circular No. 2014-018 Dated 15 August 2014 Entitled Manufacture, Sale, and Distribution of Medical-Grade Oxygen |
| 18 August 2014 | FDA Circular No. 2014-019 | Moratorium on the Imposition of Penalty Fess During Renewal of LTO as Food, Drugs, Medical Devices or Cosmetic Manufacturer or Distributor |
| 01 September 2014 | FDA Circular No. 2014-020 | Submission of Compliances to Notice of Deficiencies (NODs) Relative to Registration Applications and Corrective Action / Preventive Action (CAPA) Plan based on Inspection Findings |
| 16 September 2014 | FDA Circular No. 2014-021 | Transition period for the Implementation of AO 2014-0029 and Application Holiday for Certificate of Product Registration for Raw Materials Superseding FDA Memorandum Circular (FMC) No. 2013-032, FMC No. 2013-035 |
| 22 September 2014 | FDA Circular No. 2014-022 | Notification of Registered Imported Wines with New Vintage |
| 26 September 2014 | FDA Circular No. 2014-023 | Guideline on the Manual Notification of Toys and Childcare Articles (CCA's) |
| 16 October 2014 | FDA Circular No. 2014-023-A | Addendum to FDA Circular No. 2014-023 Dated 26 September 2014 Subject : Guidelines on the Manual Notification of Toys and Childcare Articles |
| 30 September 2014 | FDA Circular No. 2014-024 | Rules and Regulations on Securing FDA Authorization for Food and Cosmetic Micro Enterprises and their Products in Collaboration with Department of Trade and Industry (DTI) Negosyo Centers and Local Government Units (LGU's) |
| 21 November 2014 | FDA Circular No. 2014-025 | Guideline on Implementation of New Rules and Regulation on Licensing of Drugstore / Pharmacy / Botica and Similar Outlets following Administrative Order No. 2014-0034, dated 13 October 2014 |
| 21 November 2014 | FDA Circular No. 2014-026 | Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Distributors following Administrative Order No. 2014-0034, dated 13 October 2014 |
| 21 November 2014 | FDA Circular No. 2014-027 | Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Manufacturer following Administrative Order No. 2014-0034, dated 13 October 2014 |
| 21 November 2014 | FDA Circular No. 2014-028 | Guideline on the Implementation of New Rules and Regulation on Licensing of Retail Outlet for Non-Prescription Drugs (RONPD's) following Administrative Order No. 2014-0034, dated 13 October 2014 |
| 28 November 2014 | FDA Circular No. 2014-029 | Procedure for the Use of Electronic Registration (E-Registration) System for Raw Materials or Ingredients and Low Risk Pre-Packaged Processed Food Products |
| 14 April 2015 | FDA Circular No. 2015-008 | Updates and Amendments of ASEAN Cosmetic Directive (ACD) |
| 10 April 2015 | FDA Circular No. 2015-007 | Rules and Regulation on the Licensing of Hospitals and Other health facilities Involved in the Manufacture of Medical Gases |
| 13 April 2015 | FDA Circular No. 2015-006 | New LTO Format for Drug Establishments following Administrative Order No. 2014-0034 |
| 09 February 2015 | FDA Circular No. 2015-001-A | Amendment to FDA Circular No. 001, Clarification on the Regulations Governing Principal and Identical Drug Products as defined under Administrative Order No. 2005-0031 |
| 24 September 2019 | FDA Circular 2019-006 | GUIDELINES IN COMMERCIAL DISPLAY, SELLING, PROMOTION, AND ADVERTISING OF ALCOHOLIC BEVERAGES AND BEVERAGES THAT CONTAIN ALCOHOL |
| 16 September 2019 | FDA Circular 2019-005 | Updates and Amendments of the ASEAN Cosmetic Directive (ACD) as Adopted During the 30th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings |
| 11 February 2019 | FDA Circular 2019-002 | Updates and Amendments of the ASEAN Cosmetic Directive (ACD) as Adopted During the 29th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings • FDA Circular - 29th ACC Annex A • FDA Circular - 29th ACC Annex B • FDA Circular - 29th ACC Annex C |
| 4 February 2019 | FDA Circular 2019-001 | Training Course/Seminars and Schedule of Fees for the Trainings Offered by the Food and Drug Administration (FDA) Academy - Policy and Planning Service (PPS) for Calendar Year 2019 |
| 13 August 2013 | Administrative Order No. 2013-0022 | Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers |
| 23 January 2019 | FDA Circular No. 2018-011-A | Amendment of FDA Circular No. 2018-011 "Schedule of Unified Licensing Seminar for Calendar Year 2018 |
| 20 August 2018 | FDA Circular No. 2018-010 | Amendment to BFAD Memorandum entitled "Guidelines for the Transshipment of Salt" dated 02 October 2004 and repeal of FDA Memorandum No. 2013-050 dated 25 July 2013 |
| 9 July 2018 | FDA Circular No. 2018-009 | Updates and Amendments of the ASEAN Cosmetic Directives (ACD) as Adopted During the 28th ASEAN Cosmetic Committee (ACC) Meetings and Its Related Meetings |
| 29 March 2018 | FDA Circular No. 2018-007 | Reiteration on the Classification of Cuticle Tints Containing Benzalkonium Chloride with Antiseptic, Antibacterial or Disinfectant Claim as Household Remedy |
| 16 March 2018 | FDA Circular No. 2018-006 | Reiteration of the Rules and Regulations for Consumer Protection in a Transaction Made Through Electronic Means as Prescribed under the Joint-DOH-DA- Administrative Order No. 01 Series of 2018 |
| 16 March 2018 | FDA Circular No. 2018-005 | Training Courses / Seminar and Schedule of Fees for the Trainings Offered by the Food and Drug Administration (FDA) Academy - Policy Planning Service (PPS) for Calendar Year 2018 |
| 6 March 2018 | FDA Circular No. 2018-004 | Guidelines for Payment of Applications with the Radiation, Regulation Division of the Center for Device, Regulation, Radiation Health and Research • Annex GUIDELINES FOR PAYMENT PORTAL for posting |
| 29 January 2018 | FDA Circular No. 2018-003 | Updates and Amendment of the ASEAN Cosmetic Directive as Adopted During the 27th ASEAN Cosmetic Committee (ACC) Meeting and its Related Meetings |
| 26 January 2018 | FDA Circular No. 2018-002 | Training Courses/Seminar and Schedule of Fees for Regional Licensing Seminar for Drugstores and Outlets (LSD-O) and Pharmacovigilance (PV) regulations and Guidelines for PV Officers Offered by the Food and Drug Administration |
| 24 January 2018 | FDA Circular No. 2018-001 | Reiteration the Mandatory Implementation of Article 8 of the ASEAN Cosmetic Directive "Product Information" |
| 3 April 2017 | FDA Circular 2017-001 | Training Courses/Seminar and Schedule of Fee for the Training Offered by the Food and Drug Administration (FDA) Academy - Policy Planning Service (PPS) for Calendar Year 2017 |
| 24 May 2017 | FDA Circular 2017-001-A | Amendment of FDA Circular No. 2017-001 |
| 27 June 2017 | FDA Circular 2017-002 | Training Courses/Seminars and Schedule of Fees for the Qualified Person in Industry Regulatory Affairs (QPIRA) Training - Accreditation Offered by the Food and Drug Administration (FDA) Academy - (PPS) for Calendar Year 2017 |
| 21 June 2017 | FDA Circular 2017-003 | Strict Implementation of the Mandatory Requirement to Secure a License to Operate (LTO),Certificate of Product Registration (CPR) or any authorization from FDA Prior to Engaging in the Manufacture, Importation, Exportation, Sale, Offering for Sale, Distribution, Transfer, Promotion, Advertisement and/or Sponsorship of Medical Devices |
| 10 August 2017 | FDA Circular 2017-006 | Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 25th ASEAN Cosmetic Committee Meeting and Its Related Events |
| 07 August 2017 | FDA Circular 2017-007 | Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 26th ASEAN Cosmetic Committee Meeting (ACC) and Its Related Events |
| 25 August 2017 | FDA Circular 2017-008 | Guidelines on the Requests for Transfer of Payments made to the Food and Drug Administration Offices |
| 25 August 2017 | FDA Circular 2017-009 | Guidelines on the Requests for Refund of Payments made to the Food and Drug Administration Offices |
| 15 September 2017 | FDA Circular 2017-010 | New Collection Policy and Procedure |
| 26 October 2017 | FDA Circular 2017-012 | Training Courses/Seminars and Schedule of Fees for Regional Licensing Seminar for Drugstores and Outlets (LSD-O) Offered by the Food and Drug Administration (FDA) Academy – Policy and Planning Service (PPS) for Calendar Year 2 |
| 17 December 2017 | FDA Circular 2017-014 | New Procedure in the Application of the Variation of Certificate of Product Registration for Medical Devices |
| 22 January 2016 | FDA Circular 2016-001 | Reiteration of FDA Memorandum Circular No. 2015-003 dated 06 February 2015 and FDA Memorandum Circular No. 2014-014-A of the Guidelines on the Placement of Advertisement in all Forms of Mass and Social Media, Billboards and Pu |
| 06 June 2016 | FDA Circular 2016-005 | Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 23rd ASEAN Cosmetic Committee Meeting and Its Related Events |
| 12 July 2016 | FDA Circular 2016-009 | Reiteration on the Classification of Diaper Rash Creams / Lotions / Ointments / Powders and Other Products Containing Zinc Oxide |
| 18 July 2016 | FDA Circular 2016-010 | New Procedures for Filling of Application for Medical Device Product Registration and Medical Device Establishment License |
| 17 August 2016 | FDA Circular 2016-010-A | Amendment of FDA Circular No. 2016-010: New Procedure for Filling of Application for Medical Device Product Registration and Medical Device Establishment |
| 09 August 2016 | FDA Circular 2016-013 | Guidelines on the Implementation of the Joint Food and Drug Administration (FDA) - National Meat Inspection Service (NMIS) Administrative Circular No. 02 on the Transfer of Function in the Regulation of Processed Meat |
| 25 July 2016 | FDA Circular 2016-012 | Guidelines on Product Recall |
| 12 August 2016 | FDA Circular 2016-014 | Procedure for the use of Electronic Registration (E-Registration) System for Prepackaged Processed Food Products |
| 1 August 2016 | FDA Circular 2016-015 | New Procedures for Filing of Application for Certificate of Health Related Device Registration for Water Purification Equipment and Devices and Certificate of Product Registration (CPR) for Equipment or Devices Used for Treati |
| 22 August 2016 | FDA Circular 2016-016 | Updates and Amendments of ASEAN Cosmetic Directive as Adopted During 24 ASEAN Cosmetic Committee Meeting and Its Related Events |
| 04 October 2016 | FDA Circular 2016-018 | New FDA Director General |
| 02 November 2016 | FDA Circular 2016-020 | New Procedure for Filing ann Application for an AFR Safety Evaluation Report and Clearance for Customes Release thru the Food and Drug Administration (FDA) Public Assistance, Information, and Receiving (PAIR) of the FDA |
| 28 October 2016 | FDA Circular 2016-021 | New Procedure for Filing an Application for a License to Operate thru the Food and Drug Administration (FDA) Public Assistance, Information, and Receiving (PAIR), Department of Health Regional Field Offices and FDA Regional Of |
| 10 February 2004 | Bureau Circular No. 02 s. 2004 | GINKGO BILOBA |
| 25 February 2014 | FDA Circular No. 2014-007 | Adoption of the Kuala Lumpur Principles Device Sector Codes of Ethics |
| 16 May 2014 | FDA Circular No.2014-014 | Minimum Number of Sample Units Required for Each Test Analysis |
| 02 November 2011 | FDA Circular No.2011-004 | Computation of Surcharge or Penalty Imposable in case of Submission of Renewal Applications Covering License of Establishments and Registration of Health Products After Their Date of Expiration Pursuant to Section 3, Paragraphs (A)(2) and (B)(2) of Article I of Book II of the RA 9711 Implementing Rules and Regulations, and Other Purposes |
| 02 May 2016 | FDA Circular-004 | Procedure on the Use of the New Application Form for License To Operate (LTO) the the Food and Drug Administration (FDA) Electronic (e-portal) |
| 24 July 1985 | Administrative Order No. 123-A s. 1985 | Standard for Banana Sauce |
| 20 November 1996 | Administrative Order No. 39 s. 1996 | Amendment to DOH-Administrative Order No. 18-A S. 1993 or the Standards of Quality and Requirements for the processing, packaging and labelling of Bottled drinking water |
| 18 October 1991 | Officer Order No. 22 s. 1991 | Guidelines for the Classification of Vitamins and Minerals as Drug or as Food |
| 15 June 2016 | FDA Circular No. 2016-007 | Notification of Sources for Raw Materials, Low Risk, Medium Risk and High Risk Prepackaged Processed Food Products |
| 30 May 2013 | FDA Circular No. 2013-010-A | Amendment to FDA Circular No. 2013-010 Revised Guidelines for the Assessment of Microbiological Quality of Processed Foods |
| 27 February 2013 | FDA Circular No. 2013-010 | Revised Guidelines for the Assessment of Microbiological Quality of Processed Foods |
| 22 December 2011 | FDA Memorandum No. 2011-028 | Safety of Soy Sauce in the Philippines: CODEX Limit on 3 MCPD |
| 28 October 1986 | Executive Order No. 51 | Adopting a National Code of Marketing of Breastmilk Substitutes, Breastmilk Supplements, and Related Products. |
| 22 December 1997 | Bureau Order No. 163 s. 1997 | Specific Requirements for the Registration of Imported Food and Food Products |
| 27 March 2013 | Republic Act No. 8172 | An Act Promoting Salt Iodization Nationwide and for Related Purposes |
| 28 October 2004 | Bureau Circular No. 17 s. 2004 | Taheebo / Pau D' Arco / Lapacho |
| 26 October 2004 | Bureau Circular No. 16 s. 2004 | Guidelines on Probiotics |
| 15 January 1999 | Bureau Circular No. 02 s. 1999 | Amendment to BFAD MC No. 25, s.1992 otherwise known as "Additional Labeling Requirement for Food Supplements" |
| 08 September 2014 | Administrative Order No. 2014-029 | Rules and Regulations on the Licensing of Food Establishments and Registration of Processed Food, and the Other Food Products, and for Other Purposes |
| 28 December 2007 | Administrative Order No. 2007-0044 | Amendment to Section VIII.3 of Administrative Order No.18-A S. 1993 Dated January 23,1993 entitled Standards of Quality Requirements for the Processing,Packaging and Labelling of Bottled Drinking Water |
| 21 June 2006 | Administrative Order No. 2005-0016 | General Policies and Guidelines Governing Brand Names of Products for Registration with the Bureau of Food and Drugs |
| 20 April 1977 | Administrative Order No. 325 s. 1977 | Regulation B-4 Definition and Standard for Foods 4.9 Condiments, Sauces and Seasoning 4.9-04 Standard of Identify and Quality for Patis |
| 18 March 2013 | Administrative Order No. 239 s. 1975 | Regulation B-4 Definition and Standards of Food B-4.13 Jams (Fruits Preserves) B-4.13-02 Jellies (Naming the Fruits) |
| 04 May 2012 | FDA Order No. 2012-001 | Rules of Procedure and Requirements for the Food and Drug Administration 's Accreditation of Private Testing Laboratories |
| 16 December 1974 | Administrative Order No. 233 s. 1974 | Regulation B-1 Definitions and Standards for Food B-1.6 Condiments, Sauces, Seasoning B-1.9-01 Tomato Catsup (Catsup) |
| 16 December 1974 | Administrative Order No. 232 s. 1974 | Regulation B-4 Definitions and Standards for Food B-4.18 Margarine |
| 20 December 1974 | Administrative Order No. 231 s. 1974 | B-4 Definitions and Standards for Food B-4.15 Fats and Oils B-4.15-02 Lard |
| 16 December 1974 | Administrative Order No. 228 s. 1974 | B-4 Definitions and Standards for Food B-4.17 Nut Products B-4.17-01 Peanut Butter |
| 12 November 1973 | Administrative Order No. 200-A s. 1973 | Regulation B-4 Definitions & Standards of Identity for Foods, B-4.5 Cheese and Cheese Products |
| 30 August 1971 | Administrative Order No. 154 s. 1971 | Regulation B-4 Definition and Standards of Identity for Foods; A.14 Meat and Meat Products. A.14.01 Sausages |
| 13 May 2014 | Administrative Order No. 134 s. 1970 | Regulation Prescribing the Standard of Identity and Quality of Vinegar (B-4.9 Condiments, Sauces, Seasonings) |
| 20 October 1970 | Administrative Order No. 132 s. 1970 | Regulation Prescribing the Standards of Identity and Quality of Milk and Milk Products (B-4.12-01) |
| 24 August 1970 | Administrative Order No. 128 s. 1970 | Regulation Prescribing the Standard of Identity and Quality for Bagoong (Fish or Shrimp) B-4.9 03 Condiments, Sauces, Seasonings) |
| 22 August 2014 | Administrative Order No. 88-A s. 1984 | Regulatory Guidelines Concerning Food Additives |
| 17 September 2001 | Administrative Order No. 50 s. 2001 | Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs |
| 23 July 1993 | Administrative Order No. 18-A s. 1993 | Standards of Quality and Requirements for the Processing, Packaging and Labeling of Bottled Drinking Water |
| 08 June 2000 | BFAD Circular No. 03-A s. 2000 | Amendment to FDA Circular No. 2 s. of 1982 on the Importation of Semi-Synthetic Antibiotics |
| Republic Act No. 8976_IRR | “AN ACT ESTABLISHING THE PHILIPPINE FOOD FORTIFICATION PROGRAM AND FOR OTHER PURPOSES |
|
| 18 October 2010 | FDA Memorandum Circular No. 2010-020 | Suspension of Manufacture, Importation,Distribution, and/or Marketing of all rosiglitazone-containing products |
| 18 October 2010 | FDA Memorandum Circular No. 2010-019 | Suspension of Manufacture, Importation,Distributiof Sibutramine Products |
| 13 June 1980 | Administrative Order No. 90-A s. 1980 | Name of Fruit Beverages |
| 15 June 1989 | Memorandum Circular No. 13 s. 1989 | Methanol Content in Alcohol Beverages as defined by Memo-Circular 88-003 |
| 11 March 2008 | Department Circular No. 2008-0064 | Certain Provisions of Administrative Order No. 2006-0012 declared as ineffective |
| 09 January 2008 | Department Circular No. 2008-0006 | Labeling of Milk and Milk Products |
| 08 August 2013 | Republic Act No. 10611 | Food Safety Act of 2013 |
| 22 June 2015 | FDA Circular No. 2015-005-A | Amendment to FDA Circular 2015-005, “Guidelines on the Use of “Saktong Iodine sa Asin” Quality Seal” |
| 15 April 2015 | FDA Circular No. 2015-005 | “Guidelines on the Use of “Saktong Iodine sa Asin” Quality Seal” |
| 12 November 1973 | Administrative Order 200-A s. 1973 | Definitions and Standards of Identity for Foods: Cheese and Cheese Products |
| 20 October 1970 | Administrative Order 132 s. 1970 | Regulation Prescribing the Standards of Identity, Quality of Milk and Milk Products (B-4.12-01) |
| 29 March 2010 | FDA Circular No 2010-008 | Adoption of the Codex Standards on Food Contaminants in Processed Food |
| 13 December 2012 | FDA Circular No 2012-015 | Guidelines on Voluntary Declaration of the front of pack labeling (energy or calorie count) on the labels of processed food products |
| 23 January 2007 | Bureau Circular No. 2007-002 | Guidelines in the Use of Nutrition and Health Claims in Food |
| 18 October 2006 | Bureau Circular No. 2006-016 | Updated list of food additives |
| 15 May 2006 | Administrative Order No. 2006-0012 | Revised Implementing rules and Regulations of Executive Order No. 51, Otherwise known as the "Milk Code" |
| 09 August 2005 | Bureau Circular No. 16 s. 2005 | Adopting the 2002 Recommended Energy and Nutrient Intakes as the new Dietary Standard |
| 16 November 2017 | FDA Circular No. 2017-013 | Guidelines on the Issuance of Clearance for Customs Release of Radiation Devices by the Food and Drug Administration - Center for Device Regulation, Radiation Health and Reaserch |
| 11 January 2005 | Administrative Order No. 2005-0003 | Guidelines on the Issuance of Certificate of Product Registration for Water Purification Equipment and Devices |
| 25 February 2014 | FDA Memorandum Circular No. 2014-005 | Updated List of Medical Devices Required to be Registered Prior to Sale, Distribution and Use |
| 26 January 2018 | Administrative Order No. 2018-0002 | Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements |
| 25 June 2019 | Administrative Order No. 2019-0019 | Reinstatement of Requirements of Licensing as Importers, Exporters, Manufacturers, Toll Manufacturers, Wholesalers, Distributors, Retailers or Repackers of those engaged in certain Household/Urban Hazardous Substances, and from the Requirement of Prior Registration and/or Notification of Said Products |
| 09 August 2019 | FDA Circular No. 2019-004 | Ban of Bisphenol A (BPA) from Infant Feeding Bottles and Sippy Cups as Child Care Article Products |
| 20 February 2015 | FDA Circular No. 2015-002 | Guidelines on the Electronic Notification of the Toys and Childcare Articles(TCCAs) |
| 03 September 2013 | Republic Act No. 10620 | An Act Providing for Toy and Game Safety Labeling, Appropriating Funds Therefor |
| 12 July 2016 | FDA Circular No. 2016-008 | Recognition of Licenses and Identification (IDs) cards Issued by the Fertilizer and Pesticide Authority (FDA) to Pest Control Operators (PCOs) and Pesticide Applicators, Respectively |
| 08 August 2017 | FDA Circular No. 2017-005 | List of Banned Pesticides |
| 27 December 2017 | FDA Circular No. 2017-015 | Adoption of the ASEAN Cosmetic Directive (ACD) Annexes II and VI as Standards for Household/Urban Pesticides |
| 18 June 2018 | FDA Circular No. 2018-008 | Ban on Chlorpyrifos and Dichlorvos for Use in Household/Urban Pesticide Products and Household/Urban Pesticide Products Containing Chlorpyrifos and Dichlorvos as Active Ingredients |
| 18 June 2019 | Administrative Order No. 2019-010 | Guidelines on the Regulation of Operators of Pest Control, Certification of Pesticide Handlers and Accreditation of their Training Providers |
| 14 June 2019 | Administrative Order No. 2019-0008 | New Rules and Regulations in the Registration of Household Pesticide Products and Their active Ingredients |
| 31 July 2015 | FDA Memorandum Circular No. 2015-011 | Guidelines for Electronic Notification of Cosmetic Products (Cosmetic E-Notification Version 2.0) Using the FDA E-Portal |
| 16 July 2015 | FDA Memorandum Circular No. 2015-010 | Guidelines on Issuance of Center for Cosmetic Regulation and Research (CCRR) User account to Access E-Portal |
| 07 May 2012 | Administrative Order No. 2009-0005-B | Addendum to DOH Administrative Order No. 2009-0005 "Revised Policies and Guidelines on the Regulations on the Issuance of a License to Operate (LTO), Certificate of Conformity and Clearance for Customs Release Prescribed to Manufacturers, Importers and Distributors of Toys in the Philippines |
| 14 December 2011 | Administrative Order No. 2009-005-A | Addendum to Administrative Order No. 2009-0005 Revised Policies and Guidelines on the Regulations on the Issuances of a License to Operate (LTO), Certificate of Conformity and Clearance for Customs Release Prescribed to Manufacturers, Importers and Distributors of Toys in the Philippines |
| 12 January 2009 | Administrative Order No. 2009-0005 | Revised Policies and Guidelines on the "Regulations on the Issuances of a License to Operate (LTO), Certificate of Conformity and Clearance for Customs Release Prescribed to Manufacturers, Importers and Distributors of Toys in the Philippines |
| 06 October 2005 | Administrative Order No. 2015-0025 | Implementation of the (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents |
| 21 April 2005 | Administrative Order No. 2005-0015 | Adoption of the Association of Southeast Asia Nation (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents |
| 10 October 2007 | Bureau Circular No. 2007-010 | Guidelines in the Initial Issuance and Renewal of License to Operate for Iron Rice Premix Manufacturer / Repacker / Importer and Setting Forth the Standards for Iron Rice Premix |
| 06 October 2005 | Administrative Order No. 2015-025 | Implementation of the (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents |
| 21 April 2005 | Administrative Order No. 2005-015 | Adoption of the Association of Southeast Asia Nation (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents |
| 20 October 2004 | Bureau Circular No. 15 s.2004 | Guidelines on Advertising, Promotion, and other Marketing Materials for Breast milk substitutes, Breast milk Supplement, and Other Related Products |
| 20 October 1998 | Bureau Circular No. 6-A s. 1998 | Permissible Net Content Variation in Pre-Packaged Food |
| 19 July 2005 | Administrative Order No. 4-A s. 1995 | Guidelines on Micronutrient Fortification of Processed Foods |
| 28 October 1986 | Executive Order 51 | Adopting a National Code of Marketing of Breastmilk Substitutes, Breastmilk Supplements, and Related Products. It will Take Effect 30 Days after Publication in the Official Gazette |
| 07 September 1982 | FDA Regulation No. 001-A s. 1982 | Guidelines for the Open-Date Marking of Liquid Milk Products, Pursuant to A.O. No. 16 S 1979 |
| Administrative Order No. 2014-0030 | “Revised Rules and Regulations Governing the Labeling of Prepackaged Food Products Further Amending Certain Provisions of Administrative Order No. 88-B s. 1984 or the “Rules and Regulations Governing the Labeling of Prepackaged Food Products Distributed in the Philippines,” and For Other Purposes | |
| Bureau Circular No. 16 s. 2004 | Guidelines on PROBIOTICS | |
| Republic Act No. 9711 | AN ACT STRENGTHENING AND RATIONALIZING THE FOOD AND DRUGS (BFAD) BY ESTABLISHING ADEQUATE TESTING LABORATORIES AND FIELD OFFICES, UPGRADING ITS FQUIPMENT, AUGMENTING ITS HUMAN RESOURCE COMPLEMENT, GIVING AUTHORITY TO RETAIN ITS INCOME, RENAMING IT THE FOOD AND DRUG ADMINISTRATION (FDA), AMENDING CERTAIN SECTIONS OF REPUBLIC ACT NO. 3720, AS AMENDED, AND APPROPRIATING FUNDS THEREOF | |
| Department Circular No. 2011-0101 | The Rules and Regulations Implementing Republic Act No. 9711 -The Food and Drug Administration Act of 2009 | |
| FDA Circular No. 2013-018 | Adoption of the International Conference on Harmonization (ICH) Safety and Efficacy Guidelines | |
| FDA Circular No. 2013-019 | Organization of the ASEAN Common Technical Dossier (ACTD) for the Registration of Pharmaceutical Products for Human Use | |
| FDA Circular No. 2013-023 | Clarification on the Provisions of Administrative Order No. 2013-0022, on the Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers | |
| FDA Circular No. 2013-025 | Amendment of the Product Registration (CPRs) of Drug Products | |
| FDA Circular No. 2013-026 | Adoption of the ICH Harmonised Tripartite Guideline, Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products Q5C | |
| FDA Circular No. 2013-027 | Waiver of Initial and Renewal Application Fees for License to Operate as Drug Outlets or Pharmacies in Calamity Areas in Leyte and Eastern Samar until December 31, 2014, and for Other Purposes | |
| FDA Circular No. 2013-028 | Suspension of Manufacture,Importation, Distribution, and/or Marketing of Ketoconazole Oral Products | |
| FDA Circular No. 2014-008 | Application Process and Requirements for Post-approval Changes of Pharmaceutical Products | |
| FDA Circular No. 2014-009 | Filing and Submission of Applications for the Approval of Clinical Trial Protocol, Compassionate Special Permit (CSP), Import Permit for Investigational Drug Products, Pharmacovigilance, Adverse Events/Adverse Reaction Reports | |
| FDA Circular No. 2014-010 | Sale and Distribution of Empty Gelatin Capsules | |
| FDA Circular No. 2014-013 | Re-Assessment of the Application of Stem Cell Therapy for Corneal Resurfacing with Limbal Stem Cells | |
| FDA Circular No. 2014-015 | Manufacture, Sale and Distribution of Traditional and Alternative Medicines | |
| FDA Circular No. 2014-017 | Procedure in the submission and issuance of the Food and Drug Administration Certification for Animal Feeds and Feed Products | |
| FDA Circular No. 2014-018 | Manufacture, Sale and Distributiron of Unregistered Medical Grade Oxygen | |
| FDA Circular No. 2014-020 | Submission of Compliances to Notice of Deficiencies (NODs) Relative to Registration Applications and Corrective Action / Preventive Action (CAPA) Plan based on Inspection Findings | |
| FDA Circular No. 2014-018-A | Amendment to FDA Circular No. 2014-018 Dated 15 August 2014 Entitled Manufacture, Sale, and Distribution of Medical-Grade Oxygen | |
| FDA Circular No. 2014-025 | Guideline on Implementation of New Rules and Regulation on Licensing of Drugstore / Pharmacy / Botica and Similar Outlets following Administrative Order No. 2014-0034, dated 13 October 2014 | |
| FDA Circular No. 2014-026 | Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Distributors following Administrative Order No. 2014-0034, dated 13 October 2014 | |
| FDA Circular No. 2014-027 | Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Manufacturer following Administrative Order No. 2014-0034, dated 13 October 2014 | |
| FDA Circular No. 2014-028 | Guideline on the Implementation of New Rules and Regulation on Licensing of Retail Outlet for Non-Prescription Drugs (RONPD's) following Administrative Order No. 2014-0034, dated 13 October 2014 | |
| FDA Circular No. 2015-001 | Clarification on Regulation Governing Principal and Identical Drug Products as defined under Administrative Order No. 2015-0031 | |
| FDA Circular No. 2015-004 | List of Reference Biotherapeutic Products (RBPs) for Head-to-Head Comparability Studies of Similar Biotherapeutic Products (SBPs) | |
| FDA Circular No. 2015-003-A | Amendment to FDA Circular No. 2015-003, Guidelines on the Implementation of New Rules and Regulations on the Licensing of Sponsors and Contract Research Organizations (CROs) following Administrative Order No. 2014-0034, dated 13 October 2014 | |
| FDA Circular No. 2015-003 | Guidelines on the Implementation of New Rules and Regulation on the Licensing of Sponsors and Contract Research Organizations (CROs) following Administrative Order No. 2014-0034, dated 13 October, 2014 | |
| FDA Circular No. 2015-010 | Adoptation of the Public Assistance, Information and Receiving (PAIR) Process of the DOH Regional Office XI for License to Operation (LTO) Application | |
| FDA Circular No. 2015-011 | Guidelines on Implementing FDA Circular No. 2014-011 on Adoptation of Unique Global Product Identification Number for Drug Products | |
| FDA Circular No. 2015-012 | Additional Requirements for the Effective Implementation of FDA Circular No. 2013-014, List of Products Requiring Bioequivalence (BE) Studies as part of the Application for the Marketing Authorization in Addition to Rifampicin | |
| FDA Circular No. 2015-013 | Adoptation of the Public Assistance, Information and Receiving (PAIR) Process of the Department of Health (DOH) Regional Office III for License to Operate (LTO) Applications | |
| FDA Circular No. 2016-002 | Training Course and Schedule of Fees for the training Offered by the Food and Drug Administration (FDA) Academy - Human Resource Development Division for Calendar Year 2016 | |
| FDA Circular No. 2016-006 | New Format of License to Operate (LTO) for Establishments Regulated by the FDA | |
| FDA Circular No. 2014-008-A | Amendment to Annex B, Notification for Minor of FDA Circular No. 2014-008 entitled "Application Process and Requirements for Post-Approval Changes of Pharmaceutical Products", Specially on Section IV, C, D, and E for Minor variation-Notification | |
| FDA Circular No. 2016-011 | Moratorium on the Implementation of FDA Circular No. 2015-011 entitled " Guidelines on Implementing FDA Circular No. 2014-011 on Adoption of Unique Global Product Identification Number for Drug Products" | |
| FDA Circular No. 2016-017 | Additional Post-Approval Changes for Pharmaceutical Products | |
| FDA Circular No. 2016-019 | Revised Guidelines on the Submission of Equivalence Evidence for Registration of Pharmaceutical Products | |
| FDA Circular No. 2017-004 | Reiteration of the Rule on Licensing Application Requiring Prior Inspection Pursuant to Administrative Order No. 2016-0003 dated February 15, 2017 | |
| FDA Circular No. 2017-011 | New Batch Notification Form and Procedure | |
| FDA Circular No. 2018-011 | Schedule of Unified Licensing Seminar for Calendar Year 2018 | |
| FDA Circular No. 2018-012 | Rescinding FDA Circular No. 2013-004 and Instituting Post-marketing Surveillance (PMS) Requirements for New Drugs under Monitored Release | |
| FDA Circular No. 2018-013 | Risk Management Plan (RMP) for Drug Establishments | |
| FDA Circular No. 2018-014 | Validity of Certificates of Product Registration (CPRs) in the Pilot Project Review of the Over-the-Counter Medicines Application (ROTCA) Medicines | |
| Administrative Order No. 2008-0033 | Rules and Conditions in Exempting Antibiotic Drug Products from the Batch Certification Requirement Amending for this Purpose Item III (C) and (D) of Administrative Order No. 103 s. 2002 "Batch Certification of Antibiotics", and for Other Purposes. | |
| Administrative Order No. 2010-0005 | Establishment of the National Center for Pharmaceutical Access and Management (NCPAM) Under the Office of the Secretary of Health | |
| Administrative Order No. 2010-0012 | Policy Requiring the Temporary Suspension of Acceptance by the Food and Drug Administration of Initial Applications for Drug Product Registration and Criteria for Refusal of Applications for Renewal of Drug Products with More than One Hundred (100) Registered Pharmaceutical Formulations | |
| Administrative Order No. 2010-0032 | Guidelines and Mechanism to Implement the Provisions of Republic Act No. 9994, Otherwise Known as "The Expanded Senior Citizens Act of 2010", on the Sale of Medicines and the Sharing of the 20% Senior Citizens' Discount | |
| Administrative Order No. 2011-0012 | Implementing Guidelines on Electronic Drug Price Monitoring System (EDPMS) version 2.0 | |
| Administrative Order No. 2006-0009 | Guidelines Institutionalizing and Strengthening the Essential Drug Price Monitoring System (EDPMS) | |
| Administrative Order No. 2012-0024 | Amendment to A O No. 50 s. 2001 Covering Fees and Charges for Accreditation of Bioequivalence Testing Centers and Private Testing Laboratories, as well as ,Audits and Inspection | |
| Administrative Order No. 1 s. 2000 | Banning and Withdrawal of Trovafloxacin (Trovan) from the Market | |
| Administrative Order No. 1 s. 2001 | Granting of Provisional Accreditation to Pharmaceuticals Suppliers | |
| Administrative Order No. 2005-0001 | Revised Policies and Guidelines Governing Patent and Trade Secret Rights in relation to the Registration of Pharmaceutical Products | |
| Administrative Order No. 3 s. 2001 | Recalling A.O. No. 99 s. 2000 Providing for the Banning and Withdrawal for the Fixed-Dose Combination Drug Product Loratidine + Pseudoephedrine (Clarinase) from the Market | |
| Administrative Order No. 4 s. 1992 | Policy and Requirements for Availing of Compassionate Special Permit (CSP) for Restricted Use of Unregistered Drug and Device Product/Preparation | |
| Administrative Order No. 4-A s. 2000 | Banning and Withdrawal of Olaquindox and Carbadox from the Market | |
| Administrative Order No. 5 s. 1992 | Banning of Loperamide Hydrochloride Liquid Preparation for Children | |
| Administrative Order No. 7 s. 1986 | Amending A.O. No. 133 s. 1985 Re: Guidelines on the Evaluation and Registration of Fixed Dose Combination | |
| Administrative Order No. 2005-0008 | Policy and Requirements for Availing of Special Permit for Restricted Use of Unregistered Drug and Test Kits for Human Immune Deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) | |
| Administrative Order No. 10 s. 1997 | Waiver of Test Analysis on Antibiotic Preparations and List B Prime Drugs7 | |
| Administrative Order No. 2005-0011 | Supplemental -Guidelines to Administrative Order No. 144 Series 2004, Entitled ".Guidelines for the Establishment and Operations of Botika ng ''Barangays (BnB) and Pharmaceutical Distribution (PDNs)" Relative to the Inclusion of Other Drugs which are Classified as Prescription Drugs and other Related Matters | |
| Administrative Order No. 13 s. 1999 | Hydroquinone and/or Tretinoin (Retinoic Acid) | |
| Administrative Order No. 14 s. 1993 | Non-Compliance with Regional Order No. 26 s. 1992 in Relation to Section 2.2.1.3.5 s. 1989 Dated January 3, 1989 and BFAD Memorandum Circular No.2 s.1993 Re: Cough Syrup Containing Dextromethorpan | |
| Administrative Order No. 19 s. 1998 | Delisting Dipyrone in the Registry of Drugs with the Bureau of Food and Drugs (BFAD) | |
| Administrative Order No. 14 s. 2001 | Interim Accreditation Guidelines for DOH Drugs and Medicines Suppliers | |
| Administrative Order No. 16 s. 1999 | Delisting Oral Proteolytic Enzyme-Containing Drug Products in the Registry of Drugs with the Bureau of Food and Drugs (BFAD) | |
| Administrative Order No. 19 s. 1998 | Delisting Dipyrone in the Registry of Drugs with the Bureau of Food and Drugs (BFAD) | |
| Administrative Order No. 23 s. 2000 | Implementing Rules and Regulations of Republic Act No. 8423 Otherwise Known as The Traditional and Alternative Medicine Act of 1997 | |
| Administrative Order No. 23-A s. 1996 | Guidelines on the Development and Establishment of Botica ng Barangay (BNB) | |
| Administrative Order No. 23-C s. 2000 | Policies and Guidelines on Over-The-Counter (OTC) Drug Products | |
| Administrative Order No. 27 s. 2001 | Rules and Regulations for Licensing Local Manufacturers of Vaccines and Biologic Products | |
| Administrative Order No. 28 s. 1996 | Standard Minimum Advertising Message for Anti-Diarrheal Preparations of Drug Products | |
| Administrative Order No. 2005-0030 | Guidelines and Procedure For the Automatic Renewal of the Certificate of Product Registration issued by the Bureau of Food and Drugs | |
| Administrative Order No. 31 s. 1996 | Guidelines in the Strengthening of the Implementation of the "Project Murang Gamot Presyong DOH" | |
| Administrative Order No. 2005-0031 | Guidelines and Procedure For the Issuance of the Principal Certificate of Product Registration and the Listing of Identical Drug Products based on the Identity of Manufacturer and Pharmaceutical Formulation | |
| Administrative Order No. 32 s. 1987 | Further Amending Administrative Order No. 101 s. 1969 Relative to Registration of Drugs and Pharmaceutical Specialties | |
| Administrative Order No. 33 s. 1982 | Reclassifying Ephedrine And Ephedrine-Containing Cough Syrup From “Over-The-Counter” Drugs to Prescription Drugs | |
| Administrative Order No. 2007-0006 | Amendment to Administrative Order No.46 s.1988 Re: Organizational Arrangements to Implement the National Drug Policy | |
| Administrative Order No. 23-A s. 1996 | Guidelines on the Development and Establishment of Botica ng Barangay (BNB) | |
| Administrative Order No. 2006-0021 | Supplemental Guidelines to Administrative Order (AO) 67 s.1987, Revised Rules and Regulation on Registration of Pharmaceutical Products and Bureau Circular 05 s.1997 in Evaluating New Drug Applications | |
| Administrative Order No. 341 s. 1978 | Ban on the Use of Chloroform (Trichloromathane) | |
| Administrative Order No. 283 s. 1976 | Banning and Withdrawal of Penicillin For Topical Application | |
| Administrative Order No. 220 s. 1974 | Current Good Manufacturing Practice in Manufacture, Processing, Packaging or Holding | |
| Administrative Order No. 194 s. 1973 | Ban on the Use of Diethylstilbestrol (DES) | |
| Administrative Order No. 184 s. 2004 | Guidelines on the Registration of Traditionally-Used Herbal Products | |
| Administrative Order No. 179 s. 1972 | Restricted Use of Hexachlorophene | |
| Administrative Order No. 178 s.1972 | Withdrawal of Dihydrostreptomycin from All Pharmaceutical Products Intended for Human Use | |
| Administrave Order No. 172 s. 2004 | Guidelines on the Registration of Herbal Medicines | |
| Administrative Order No. 170-2004 | Policies and Guidelines Governing Intellectual Property Rights in Relation to Registration of Pharmaceutical Products | |
| Administrative Order No. 2013-012 | Rules and Regulations Governing the Accreditation of Health Facilities Engaging in Human Stem Cell and Cell-Based or Cellular Therapies in the Philippines | |
| Administrative Order No.163-2000 | Reclassifying All Pharmaceutical Products containing more than 25 mg to 50 mg of Phenylpropanolamine to Prescription drugs and Prohibiting the Registration of those containing more than 50 mg | |
| Administrative Order No. 2012-0008 | Adoption and Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) Guides for the Good Manufacturing Practice(GMP) for Medicinal Products | |
| FDA Circular No.2019-003 | Guidelines for The Classification of Deficiencies Observed During Inspection of Drug Manufacturers | |
| FDA Circular No. 2014-016 | Implementing Guidelines for Administrative Order No. 2013-0022 dated 13 August 2013, Subject: Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers | |
| JOINT DOH and DA Administrative Order No. 2013-0026 | Rules on the Regulation of Veterinary Drugs and Products, Veterinary Biological Products, and Veterinary Drugs Establishments | |
| Administrative Order No. 2013-0027 | Adoption and Implementation of the World Health Organization Annex 5 Guide to Good Distribution Practices (GDP) for Pharmaceutical Products, and Annex 9 Guide to Good Storage Practices for Pharmaceuticals | |
| Administrative Order No. 34 s. 1979 | The Need and Role of a Medical Director in the Pharmaceutical Industry | |
| Administrative Order 2014-0016 | Adoption of the World Health Organization "Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs) for the Registration of Biosimilar Products | |
| Administrative Order No. 2011-0009 | National Policy and Program on Pharmacovigilance | |
| Administrative Order No. 144 s. 2004 | Guidelines for the Establishment and Operations of Botika ng Barangay (BnB) and Pharmaceutical Distribution Networks (PDNs) | |
| Administrative Order No. 142 s. 2004 | Bureau of Food and Drugs (BFAD)'s issuance of Certificate of Product Registration for Foreign Assisted Projects Procurement and Laboratory Testing Pharmaceutical and Biological Products Procured by and/or Delivered to the Department of Health (DOH) | |
| Administrative Order No. 64 s. 2003 | Policy Guidelines on the Operationalization of Botika ng Barangays (BnBs) by the Center for Health Development (CHD) | |
| Administrative Order No. 34 s. 2003 | Guidelines in the Operationalization of Botika ng Barangay at CHD III Pilot Areas | |
| Administrative Order No. 103 s. 2002 | Batch Certification of Antibiotics | |
| Administrative Order No. 70 s. 2002 | Licensing of Botika ng Barangay (BnB) in Various Local Government Units | |
| Administrative Order No. 53 s. 2001 | Recalling Administrative Order No. 40 s. 2001 | |
| Administrative Order No. 149 s. 1971 | Unauthorized Purchase, Possession, Display or Sale of Government-Owned Drugs, Medicines or Any Other Medicinal Items | |
| Administrative Order No. 131 s. 1970 | Regulation Part C-3.2: Drugs: Prohibition of Use of More Than One Name for a Given Formulation | |
| Administrative Order No. 151 s. 1971 | Regulation Part C-7 Drug and Devices: Certification of Antibiotics | |
| Administrative Order No. 342 s. 1978 | Banning Tetracyclines for Children Under 8 years Old | |
| Administrative Order No. 96-A s. 1980 | Supplementing Administrative Order No. 81, 88 and 94 s. 1980 dated March 26, May 22 and July 10, 1980: Re-authorized ceiling of drugs and medicines that can be kept in stock by hospitals and sanitaria | |
| Administrative Order No. 24-A s. 1982 | Banning Neomycin in Anti-diarrheal Preparations | |
| Administrative Order No. 129 s. 1985 | Banning and Withdrawal of Flosint Tablets (Indoprofen) from the Market | |
| Administrative Order No. 130 s. 1985 | Banning and Withdrawal of Sulocton (Suloctidil) from the Market | |
| Administrative Order No. 64 s. 1989 | Amendment of A.O No. 55 s. 1988 Otherwise Known as Requirements for Labelling Materials of Pharmaceutical Products | |
| Administrative Order No. 147 s. 1986 | Banning and Withdrawal of Merital 25/50 mg Capsules (Nomifensine) | |
| Administrative Order No. 70 s. 1989 | Re-Classifying Pseudoephedrine and Drug Products Containing Pseudoephedrine as Prescription Drugs | |
| Administrative Order No. 91 s. 1990 | Declaring a Ban or the Use of Chloramphenicol in Food Producing Animals | |
| Administrative Order No. 93 s. 1990 | Postponement of the Deadlines of A.O 85 s. 1990 | |
| Administrative Order No. 100 s. 1990 | Regulation for the Licensing of Veterinary Drug and Product Establishments and Outlets | |
| Administrative Order No. 111-D s. 1991 | Guidelines on Advertisement and Promotions of Veterinary Drugs and Products | |
| Administrative Order No. 113 s. 1991 | Guidelines on Advertisement and Promotion of Multi-active Ingredient/Fixed Dose Combination Drug Products | |
| Administrative Order No. 41 s. 1994 | Supplemental Rules and Regulations in Registration of Pharmaceutical Products Entitled to a Conditional Certificate of Product Registration | |
| Administrative Order No. 8-A s. 1995 | One-Stop-Shop Licensing Unit for Hospitals and Medical Ancillary Services | |
| Administrative Order No. 63 s. 2000 | Guidelines in the Filling of Ordinary Prescriptions (Rx) by all Drug Outlets (Drugstore, Pharmacy or Botica Including Hospital Pharmacy/Dispensary) | |
| Administrative Order No. 86 s. 2000 | The Need and Role of a Medical Director in the Pharmaceutical Industry | |
| Administrative Order No. 176 s. 2004 | Guidelines in the Use of Albendazole or Mebendazole in the Treatment of Soil-Transmitted Helminthiasis in Children 12 Months Old and Above | |
| Administrative Order No. 2012-0007 | GUIDELINES ON THE GRANT OF TWENTY PERCENT (20%) DISCOUNT TO SENIOR CITIZENS ON HEALTH RELATED GOODS AND SERVICES AND FOR OTHER PURPOSES | |
| Administrative Order No. 42 | Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines | |
| Administrative Order No. 2014-0034 | Rules and Regulations on the Licensing of Establishments Engaged in the Manufacture, Conduct of Clinical Trial, Distribution, Importation, Exportation, and Retailing of Drug Products, and Issuance of Other Related Authorizations | |
| Administrative Order No. 2014-0040 | REVISED GUIDELINE ON THE NEED / ROLE OF A MEDICAL DIRECTOR IN THE PHARMACEUTICAL INDUSTRY | |
| Administrative Order No. 42 | Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines |
Civic Drive Filinvest Corporate City
(02) 8857-1900
local 1000
(02) 8842-5635
Copyright © 2023. All Rights Reserved.